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INTRODUCTION 
In recent years, there has been a renewed interest in anaerobic 
bacteriology and diseases caused by anaerobic organisms. A review of 
recent literature demonstrates that there has been an increase in the 
isolation of such bacteria from clinical specimens. In 1964, in a 5 
hospital combined study, anaerobic bacteria were reportedly isolated 
from only 2% of 1388 surgical wounds (Committee on Trauma, National 
Research Council, 1964). Bornstein et al. (1964) found that only 3% 
of specimens in the clinical laboratory contained anaerobic bacteria. 
In 1973, Davis et al. reported a 15% isolation rate from 7500 speci-
mens. Leigh (1974) studied the Bacteroides isolates during a 4 year 
time period and reported a continuous increase in rate from 13% in 
1970 to 83% in the first 6 months of 1974. The increase in rate of 
isolation of anaerobic bacteria, especially of !· fragilis, has been 
noted by other investigators (Gorbach and Bartlett, 1974; Altemeier 
et al., 1967; Thadepalli et al., 1973; Martin, 1974; Polk and Kasper, 
1977; Saksena et al., 1968). 
The reported increase in isolation of anaerobic bacteria might 
be due to a) an actual increase in the number of infections caused by 
anaerobic bacteria, b) an apparent increase in infections because of 
increased awareness of physicians as to possible presence of anaerobic 
bacteria in specimens and c) more importantly, the greatly improved 
techniques of anaerobic bacteriology. 
Certain underlying diseases are known to predispose individuals 
1 
2 
to infection by anaerobic bacteria. These include malignancies and 
diabetes. With increased longevity, the incidence of these diseases 
has increased considerably in recent years. Undoubtedly, this has 
contributed to an actual increase in the number of anaerobic infec-
tions and concomitant number of anaerobic species isolated. Other 
factors which might predispose to such infections include prolonged 
use of corticosteroids, antimicrobial agents or antineoplastic agents. 
Many investigators (Marcoux et al., 1970; Feiner and Dowell, 
1971; Clark et al., 1977; Saksena et al., 1968; Finegold et al., 1970) 
noted a striking number of malignancies associated with infection by 
anaerobic bacteria. Marcoux et al. (1970) found that of 123 patients 
with Bacteroides bacteremia, 35 had carcinoma (21 with colon carcino-
ma). In a study (Feiner and Dowell, 1971) of 250 patients with Bac-
teroides bacteremia, 57 had malignant neoplasms. Finegold et al. 
(1970) reported that 16% of 1736 patients with anaerobic infections 
had malignancies. In other studies, 25 of 174 patients (Clark et al., 
1977) and 26 of 112 patients (Saksena et al., 1968) were shown to have 
underlying malignancies. Other investigators (Chow and Guze, 1974; 
Bodner et al., 1970) have also noted the prevalence of malignant neo-
plasms in patients with anaerobic infection indicating that malignan-
cies might be a predisposing factor for anaerobic infections. 
A second important predisposing factor is previous treatment by 
antibiotics, specifically, neomycin and the other aminoglycosides. In 
one study (Marcoux et al., 1970), 75 of 123 patients with anaerobic 
infection had prior antibiotic treatment. Finegold et al., (1970) 
noted that antibiotic therapy preceded a disproportionately large 
number of anaerobic infections. These findings are supported by the 
reports of others (Bodner et al., 1970; Bornstein et a1., 1964; Sak-
sena et a1., 1968). 
3 
Diabetes (Bornstein et al., 1964; Bodner et a1., 1970; Saksena 
et a1., 1968; Finegold et al., 1970; Clark et a1., 1977), cortico-
steroid therapy (Bodner et al., 1970; Saksena et al., 1968; Finegold 
et al., 1970), organ transplants (Finegold et al., 1970), and treatm~nt 
with antineoplastic agents (Clark et al., 1977; Bornstein et al., 
1964) were also noted as being closely associated with infection by 
anaerobic bacteria. It is worth noting that in the study of Marcoux 
et al. (1970) 62% of the patients had disease of the gastrointestinal 
tract, and all patients were shown to have some form of underlying 
disease. 
Another possible reason for increased incidence of anaerobic 
infection is the increased longevity of the human population. Studies 
by Ellner and Wasilauskas (1971), Sinkovics and Smith (1970) and Felner 
and Dowell (1971) have also demonstrated an increased incidence of 
anaerobic infection with increase in age. 
The reported rise in number of anaerobic infections might also 
be due to an increased awareness by the physician as to the possible 
involvement of anaerobic bacteria in the disease process (Martin, 
1974; DeHaan et al., 1974; Clark et al., 1977). 
Infinitely more important in accounting for the apparent rise in 
number of anaerobic infections are the improved techniques of anaero-
bic bacteriology (Leigh, 1974; Appelbaum et al., 1976; Moore et a1., 
1969; Holland et al., 1977). The improved methods for sample collec-
4 
tion, transportation and storage, isolation and identification, as well 
as development of suitable culture media are jointly responsible for 
higher rates of isolation of anaerobes from clinical specimens. 
A major difficulty in the collection, transportation, and stor-
age of specimens suspected of containing anaerobic bacteria has been a 
loss in viability of the organisms due to their exposure to oxygen and 
low temperature. The effect of these parameters on clinically signi-
ficant anaerobic bacteria is important in determining appropriate 
handling of clinical specimens. Contrary to earlier beliefs, recent 
investigations have demonstrated that clinically significant anaerobic 
bacteria are quite tolerant to oxygen exposure (Bartlett et al., 1976; 
Loesche, 1969; Tally et al., 1975). In 1969, Loesche studied the 
effect of differing oxygen concentrations and time of oxygen exposure 
on a variety of anaerobic bacteria from stock cultures. From the 
results of this study, he classified the bacteria into two groups: 
strict and aerotolerant anaerobes. Although strict, or extremely 
oxygen sensitive (EOS), anaerobes can be routinely isolated from the 
normal flora by rigid anaerobic techniques, Attebery (1971) and Rosen-
blatt et al. (1974) failed to isolate any EOS organisms from clinical 
material. Onderdonk et al. (1974) did not isolate EOS from experi-
mental abscesses caused by rat cecal contents. It is now relatively 
• 
well established that most organisms commonly isolated from anaerobic 
infections are found in the moderate, or aerotolerant group of anae-
robes (Bartlett et al., 1976). Ueno (1968) found that he could iso-
late !· fragilis from pus after as long Has one week of storage. 
Since the oxygen tolerance of stock cultures may differ signifi-
cantly from that of fresh clinical isolates, Tally et al. (1975) 
compared oxygen tolerance of fresh and stored cultures of !· fragilis 
and other organisms commonly associated with anaerobic infections. 
They found that most clinically significant anaerobic bacteria could 
tolerate exposure to oxygen for at least 8 hours and frequently for 
longer periods of time. They suggested that primary isolation and 
many manipulations of anaerobic bacteria could be done on the labora-
tory bench in room air. 
In addition to the problem of oxygen exposure, clinical speci-
mens that cannot be processed immediately are often subjected to 
storage at refrigerator temperatures. This prevents the overgrowth 
of facultative forms that occurs either aerobically or anaerobically 
at room temperature. Finegold et al. (1974) recommended that speci-
mens that could not be processed within 2 hours after collection should 
be refrigerated in order to suppress the undesirable proliferation of 
coexistent facultative anaerobes. However, authors of other clinical 
laboratory manuals (Dowell and Hawkins, 1974; Holdeman and Moore, 1972) 
cautioned not to store specimens at low temperature because of possi-
ble detrimental effects of chilling on anaerobic bacteria. Other 
investigators have reported similar findings when certain facultative 
and obligate anaerobic bacteria were suddenly exposed to low tempera-
ture (Gorrill and McNeil, 1960; Hegarty and Weeks, 1940; Strange and 
Dark, 1962; Traci and Duncan, 1974). This unresolved problem as to 
the effects of low temperature needs to be further investigated. 
In the past, techniques for the isolation of anaerobic bacteria 
have been cumbersome, time consuming, and too expensive for routine 
clinical use. However, one of the major improvements in anaerobic 
bacteriology has been the development of devices that make routine 
anaerobic bacteriology possible. Three devices currently in use are: 
a) the anaerobe jar; b) the roll tube; c) the anaerobic chamber. 
6 
In early models of the anaerobe jar (Mcintosh and Fildes, 1916; 
Stokes, 1958), atmospheric oxygen was removed by catalyzing its union 
with hydrogen gas. However, the external source of explosive hydrogen 
gas posed a serious hazard. Recently a self contained gas generating 
packet has been developed (Brewer and Allgier, 1966) for production of 
a hydrogen-carbon dioxide atmosphere. The union of oxygen and hydro-
gen can be safely catalyzed, leaving a carbon dioxide atmosphere. 
Finegold (1977) demonstrated that oxygen was reduced to less than 0.2% 
of atmospheric levels by 1 hour using a commercially available gas 
generating system (GasPak, BBL). Since moderately oxygen sensitive 
anaerobes can survive and grow under these conditions (Loesche, 1969) 
and extremely oxygen sensitive anaerobes have not been recovered from 
clinical specimens (Rosenblatt et al., 1974), this system is quite 
effective in the isolation of anaerobic pathogens. Due to its ease of 
use and compact nature, this technique is now in use in most anaerobic 
bacteriology laboratories. 
The roll tube, a system in which each sample tube serves as its 
own miniature anaerobic chamber, was developed and modified by Hungate 
(1950), Bryant (1963) and Moore (1966). A much higher isolation rate 
of strict anaerobes can be obtained with this technique. However, the 
need for bulky tanks of gas and special media, and inherent mechanical 
complexity make this technique more valuable to the researchlaboratory 
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than to the clinical labs. Lastly, anaerobic chambers have been 
developed (Drasar, 1967; Aranki et al., 1969; Leach et al., 1971) in 
which to perform bacteriology on clinical specimens or study the 
growth and characteristics of the anaerobic bacteria (Drasar, 1967). 
This technique has the advantages of providing continuous anaerobic 
conditions and continuous viewing without the need of hydrogen or 
catalysts, but requires a great deal of room and a large initial 
expenditure. Studies by Killgore et al., (1972) and Rosenblatt etal., 
(1974) demonstrated that all three of these methods were comparable in 
their ability to recover anaerobes from clinical specimens. 
Many anaerobic bacteria, including clostridia, Actinomyces, Pep-
tococcus, Peptostreptococcus, Fusobacterium and Bacteroides have been 
implicated as, or shown to be, pathogenic in man. However, Bacteroi-
des, especially B. fragilis, was by far the most frequently isolated 
anaerobic bacterium from clinical infections (Holland et al., 1977; 
Lorber and Swenson, 1975; Moore et al., 1969). !· fragilis is an 
obligately anaerobic, gram negative rod which was first isolated by 
Veillon and Zuber (1897). As part of the normal flora, it makes up 
95% of the colonic bacteria, outnumbering the aerobic microorganisms 
by 100-1000 to 1. Feces contains approximately 1011 Bacteroides per 
gram of material, the predominant species being !· fragilis (Finegold 
et al., 1974). The species!· fragilis has been divided into the 5 
subspecies of fragilis, vulgatus, ovatus, thetaiotaomicron, and dis-
tasonis. Subspecies thetaiotaomicron and vulgatus have been shown to 
be isolated from 90-100% of fecal specimens from healthy volunteers 
(Ueno et al., 1974). In contrast, B. fragilis subsp. fragilis was 
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only isolated in 30-40% of the samples, and was usually 1-2 logs lower 
in concentration than the others. 
As a member of the normal flora of the body, !· fragilis plays a 
number of roles. B. fragilis in the intestinal tract is known to be a 
prime producer of vitamin K for the human body (Gibbons and Engle, 
1964). It also plays a major role in the degradation of bile acids in 
the gut and is vital to the proper recycling of these acids (Hill and 
Drasar, 1968). Treatment which reduces counts of Bacteroides in the 
mouse intestine has been shown to render mice more susceptible to 
Salmonella infections (Bohnhoff et al., 1964). 
!· fragilis has been associated with infections in virtually 
every part of the human body, the most commonly encountered clinical 
presentation being the abscess (Gorbach and Bartlett, 1972). Such 
infections almost always arise from an endogenous source, occurring 
only when the primary defense mechanisms have been breached, as in 
trauma resulting from intestinal surgery, wounds (Nicholsetal., 1972; 
Thadepalli et al., 1973) or the other predisposing diseases or defi-
ciency states mentioned earlier. These opportunistic infections are 
most commonly associated with pleuropulmonary, intra-abdominal, and 
female genital tract regions, as well as the bloodstream. In an ex-
tensive study of anaerobic isolates, DeHaan et al. (1974) reported 
that whenever anaerobes were isolated in the following cases, it was 
Bacteroides 100% of the time from osteomyelitis cases, 89% from septi-
cemias, 81% from intra-abdominal infections, 70% from infections of 
the pelvis and genital tract, 64% from lower respiratory tract infec-
tions, and 62% from soft tissue infections. Of 81 clinical specimens 
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collected from infections of various areas of the body, 17.4% were 
found to contain B. fragilis (Moore et al., 1969). In this study, the 
next most frequently isolated bacterial species was Clostridium per-
fringens, at 9%. Holland et al. (1977) found that a far greater 
percentage of B. fragilis (52%) was isolated from specimens collected 
over a 14 year time period. Martin (1974) reported a 23% isolation 
rate for B. fragilis. Other investigators have also demonstrated 
B. fragilis to be the most frequently isolated bacteria from anaerobic 
infections (Nobles, 1973; DeHaan et al., 1974). 
A study of the ~· fragilis subspecies isolated from clinical 
samples revealed that subsp. fragilis was the most frequently isolated. 
Holland et al. (1977) reported that 44% of the !· fragilis isolates 
were subsp. fragilis, and the subsp. thetaiotaomicron was next with a 
27% isolation rate. However, as mentioned earlier, !· fragilis subsp. 
fragilis is isolated much less frequently than subsp. thetaiotaomicron 
and vulgatus from normal individuals. The prevalence of infections by 
subsp. fragilis when compared to the infrequency of infections by 
subsp. thetaiotaomicron and subsp. vulgatus may indicate an sctive 
role for!· fragilis subsp. fragilis in the pathogenic process. 
Although the frequent involvement of !· fragilis in anaerobic 
infections is well documented, the exact mechanisms whereby this 
organism produces infection have never been completely elucidated. 
There are at least three major unsolved problems concerning the infec-
tions caused by!· fragilis. a) The ability of~· fragilis alone to 
cause infections has never been established. Interaction with other 
microorganisms may be necessary in the pathogenesis of such infections. 
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b) Pathogenic factors in!· fragilis have never been identified. 
c) Although many antibiotics and types of therapy have been used for 
treatment of !· fragilis infections, results show only moderate 
success. A more effective method for the prophylaxis and chemotherapy 
of B. fragilis infections needs to be developed. 
It has been speculated for some time that synergistic interac-
tions between facultative and obligate anaerobes might play an impor-
tant role in the development of intra-abdominal infections (Meleney 
et al., 1932; Altemeier, 1942; Hite et al., 1949; Finegold and Rosen-
blatt, 1973; Hill et al., 1974; Lorber and Swenson, 1975.; Stone et 
al., 1975; Onderdonk et al., 1976). However, there have only been a 
few demonstrations of actual synergistic interactions between these 
two types of microorganisms. In 1932, Meleney et al. showed that 
gangrenous lesions could be produced in guinea pigs by mixtures of 
microaerophilic, or anaerobic, streptococci, and staphylococci, but 
not by either organism alone. 
Altemeier (1942) studied the bacterial isolates from 100 cases 
of perforated appendix in humans, of which 96 cases contained both 
aerobes and anaerobes. He found that while pure cultures of organisms 
from infections were nonpathogenic, combinations were often able to 
cause progressive infections. Hite et al. (1949) demonstrated similar 
results using !· melaninogenicus, streptococci and other organisms 
found as normal flora of the oral cavity. More recently, Onderdonk et al. 
(1976) reported that intra-abdominal abscesses failed to form after 
implantation of Escherichia coli or !· fragilis alone into the peri-
toneal cavity of rats. However, abscesses were produced in 100% of 
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the animals that received the combination of these organisms, suggest-
ing that intra-abdominal abscess formation was indeed related to 
synergy between anaerobes and facultative bacteria. However, the 
nature of these interactions and the mechanisms involved are not know~ 
Despite the many reports suggesting that synergistic interac-
tions of B. fragilis and facultative anaerobes are essential for the 
development of these anaerobic infections, several investigators (Hill 
et al., 1974; Renz et al., 1975; Onderdonk et al., 1976; McConville 
et al., 1976; Walker and Wilkins, 1976) reported that~· fragilis 
alone could cause minute intra-abdominal abscesses in experimental 
animals when bacteria were inoculated along with certain materials. 
The mechanism(s) of B. fragilis pathogenicity is essentially 
unknown. ~· fragilis is not known to produce any exotoxins which 
participate in the pathogenic process, although various exoenzymes, 
endotoxin, and a capsule have been identified for this organism. B. 
fragilis has been found to produce a wide variety of extracellular 
enzymes. Various strains produced extracellular DNAase(Porschen and 
Sonntag, 1974), phosphatase (Porschen and Spaulding, 1974), peni-
cillinase, hyaluronidase, chondroton sulfatase, protease, and lipase 
(Rudek and Hague, 1976). Although these enzymes are thought to allow 
the spread of infections caused by some facultative organisms, their 
role in the pathogenic process of ~· fragilis remains to be elucidated. 
Another potentially damaging enzyme shown to be produced by B. fra-
gilis is an extracellular heparinase (Gesner and Jenkin, 1961; Bjorn-
son et al., 1970). A heparinase has been hypot~esized as being 
responsible for phlebitis and dissemination of anaerobic infections 
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(Bjornson and Hill, 1973; Felner and Dowell, 1971; LeFrock et al., 
1976; Meyer and Finegold, 1976). This type of thrombophlebitis has 
been associated with!· fragilis septicemia (Bjornson and Hill, 1973). 
However, at present, the in vivo production of a heparinase by !· 
fragilis has never been demonstrated and the role of !· fragilis 
heparinase in abscess formation still remains to be elucidated. 
Endotoxin has been identified in!· fragilis. However, Kasper 
(1976) has shown the endotoxin of !· fragilis to be much less toxic 
thari the lipopolysaccharides of Salmonella or !· coli, possibly due to 
its novel structure. !· fragilis lipopolysaccharides were shown to 
lack both 2-keto-3 deoxyoctonate and heptose, 2 essential sugars 
found in classical endotoxins (Heath et al., 1966; Osborne, 1966). A 
very loose association between polysaccharide and lipid moieties of 
the lipopolysaccharide was also demonstrated. Possibly due to these 
structural characteristics, !· fragilis endotoxin could not induce two 
classic examples of endotoxin toxicity, chick embryo lethality and the 
localized Shwartzman reaction. This might also account for the low 
incidence of disseminated intravascular coagulation in patients with 
B. fragilis sepsis, as reported by Yoshikawa et al. (1974). 
Once!· fragilis bypasses the primary defense mechanisms, it 
must somehow protect itself against the phagocytic defenses. Recent 
work by Kasper (1976) demonstrated that a capsule was produced by !· 
fragilis subsp. fragilis but was not produced by the other subspecies. 
Subsequently, Onderdonk et al. (1977) showed that capsular material 
alone was able to induce abscess formation, and that encapsulated 
strains of B. fragilis adhered to rat peritoneal epithelium better 
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than unencapsulated strains (Onderdonk et al., 1978). This might 
explain the increased frequency of isolation of subspecies fragilis 
when compared to the other subspecies. However, contrary to these 
findings, Babb and Cummins (1978) demonstrated that three of the other 
~· fragilis subspecies, vulgatus, thetaiotaomicron, and ovatus, also 
possessed capsules and cautioned that capsules may not be a unique 
pathogenic factor of subsp. fragilis. 
The third main question concerns the selection of proper and 
effective antibiotics for chemotherapy of anaerobic infections. The 
confusion arises from the question as to which organisms antibiotic 
therapy should be directed in mixed bacterial infections. Polk 
(1977) infers that only the facultative component of such infection 
needs to be treated. He found that a failure to treat surgical infec-
tions of the large intestine with cephaloridine resulted in a fourfold 
rise in infection rate. Since cephaloridine is ineffective against 
certain anaerobic bacteria, Polk inferred that anaerobic organisms 
were not the prime source of infection. It was suggested that only 
the facultative component of such infections needs to be treated. On 
the other hand, Onderdonk et al. (1976) has suggested that !· fragilis, 
in an experimental mixed infection of !· fragilis and !· coli, was a 
necessary component for abscess formation. If this hypothesis is true, 
treatment of !· fragilis alone would prevent abscesses from forming, 
but would not prevent a potentially lethal peritonitis caused by facul-
tative gram negative rods. 
Treatment of !· fragilis infections poses a very serious problem 
because of the extreme resistance of this organism to many chemothera-
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peutic agents, including aminoglycosides (Finegold and Sutter, 1971), 
&-lactam antibiotics and others (Kislak, 1972; Martinet al., 1972; 
Zabransky et al., 1973). Previously, tetracycline was the drug of 
choice for anaerobic infections. However, due to a rise in resistance 
of !· fragilis to this antibiotic (Nastro and Finegold, 1972) it is no 
longer recommended. Chloramphenicol is effective against B. fragilis, 
but is reserved for seriously ill patients due to its association with 
aplastic anemia (Finegold, 1975). Clindamycin, the 7-chloro deriva-
tive of lincomycin, has been shown to be extremely effective against 
B. fragilis (Haldane and van Rooyen, 1972). However, because of its 
association with pseudomembranous enterocolitis, now known to be 
caused by a toxin produced by Clostridium difficile (George et al., 
1977), routine therapy with this antibiotic has often been avoided 
(Cohen et al., 1973; Scott et al., 1973; Viteri et al., 1974). 
Recently, good results have been obtained with carbenicillin against 
anaerobic infections involving B. fragilis by in vitro testing 
(Sutter and Finegold, 1975) and in vivo clinical studies (Meny et al., 
1975; Swenson and Lorber, 1976). There have also been promising 
results with metronidazole in the treatment of anaerobic infections 
(Staneck and Washington, 1974; Whelan and Hale, 1973; Willis et al., 
1976; Tally et al., 1975), although this agent has not yet been 
approved by the Federal Drug Administration for use in the United 
States. 
Another problem with the treatment of anaerobic infections con-
cerns the ability of antibiotics to reach the extravascular site of 
infection (Gerding et al., 1976). A number of investigators (Alexander 
F 
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et al., 1973; Tight et al., 1975; Gerding et al., 1976) have studied 
penetration of antibiotics into subcutaneously or intraperitoneally 
implanted capsules. However, there has been great variability in 
results due to bleeding, infection, differing routes of antibiotic 
inoculation, and inconsistent degree of vascularity. 
The most prevalent thought is that until a time when patho-
genesis of these mixed infections is understood, therapy should be 
directed against all significant components of the infection, includ-
ing both aerobic and anaerobic bacteria (Finegold, 1977; Chow et al., 
1976; Thadepalli et al., 1973; Weinstein et al., 1974). Chow and 
Guze (1974) performed a prospective study in humans on the effective-
ness of various antibiotic combinations for control of both aerobic 
and anaerobic components, and indicated the need for both types of 
antibiotics. Other investigators (Bach et al., 1977; Griffith et al., 
1977) have also studied the effectiveness of various combinations of 
antibiotic therapy in humans. 
It is the purpose of this dissertation to critically investigate 
the in vivo and in vitro interactions between B. fragilis and E. coli. 
In order to approach this problem, the following studies will be 
undertaken: (1) An animal model of intra-abdominal abscess formation 
will be developed in which the ability of !· fragilis, ~· coli, or the 
combination of both organisms, to cause abscess infections in rats 
will be studied; (2) The effect of type of bacteria, inoculum size 
and suspending material on abscess formation will be studied; (3) The 
nature of the interactions between !· fragilis and !· coli will be 
studied in vitro. Finally, (4) factors produced by!· coli that 
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stimulate the growth of B. fragilis will be partially characterized. 
MATERIALS AND METHODS 
I. Isolation and maintenance of cultures. 
Bacteroides fragilis subsp. fragilis (strain 8044) and Escheri-
chia coli (strain 8077) were used throughout this study. Other 
organisms used were !· fragilis strains 2701, 8368, 7728, and 6880, 
Klebsiella pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa, and 
Staphylococcus aureus. All cultures were initially isolated from 
clinical specimens by the clinical microbiology laboratories and kindly 
provided by Dr. J. Vice, Foster G. McGaw Hospital. 
The identity of all B. fragilis strains was confirmed using 
techniques described by Holdeman and Moore (1972). These included gas 
chromatographic analysis and sugar fermentation testing. Samples were 
prepared for gas chromatographic analysis as follows. Organisms were 
grown at 37°C for 48 h under anaerobic conditions in peptone yeast 
glucose medium (PYG, Difco Labs). Volatile acids were removed by 
acidifying the culture and then extracting with ethyl ether (Mallin-
crodt, Inc.). Non-volatile fatty acids were removed from the acidi-
fied culture by adding methanol and sulfuric acid, incubating at 55°C 
for 30 min, and finally extracting with chloroform (Mallincrodt, Inc.). 
Approximately 14 ~1 of chloroform or ether was injected into a Beck-
man GC-5 gas chromatograph equipped with a hydrogen flame detector 
and a Beckman recorder. Chromosorb W 80-100 mesh in a 6' x 1/8 inch 
stainless steel column was used with LAC-1-R-296 (diethylene glycol 
+ adipate) as the partition liquid (Beckman Instruments, Inc.). 
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ne~1um gas \Liqu1a ~arooni~ ~orp.J was usea as tne carrier, and a 
combination of hydrogen and air (Liquid Carbonic Corp.) was used to 
fuel the hydrogen flame detector. 
Stock cultures of each strain were stored in 1.0 ml defibrinated 
sheep blood (BBL) at -60°C (Model SZB-659, Revco Co.). For routine 
work, cultures were maintained at 37°C on blood agar (BBL) or enriched 
media as described below. 
II. Media 
A. Liquid media. Several different complex media were used in 
these studies. Enriched trypticase soy broth (enriched TSB) consisted 
of trypticase soy broth (TSB, BBL), supplemented with 0.5% yeast 
extract (BBL), 0.05% hemin (Eastman Organic Chemical Div., Eastman 
Kodak Co.), and 0.0005% menadione (Sigma Chem. Co.), and was routinely 
used for growth and maintenance of cultures. It was also used for 
studying oxygen and cold tolerance of anaerobic bacteria. Bacto-pep-
tone (5%, Difco Labs), 5% tryptone peptone (Difco Labs), and 5% thio-
tone peptone (BBL) were tested for their ability to support growth of 
!· fragilis alone, ~· coli alone, or the combination of both. On the 
basis of these findings, Bacto-peptone was chosen for the study of 
mixed culture interactions of !· fragilis and ~· coli. 
A modification of the semi-synthetic medium of Roberts et al. 
(1955) was also used to study mixed culture interactions. The semi-
synthetic medium contained 1% Casamino acids (Difco Labs), 0.0026% 
sodi~ sulfate, 0.3% potassium phosphate (monobasic), 0.3% sodium 
chloride, and 0.0001% magnesium chloride. The pH of this medium after 
autoclaving was 7.0. For certain experiments, Bacto-peptone or semi-
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synthetic medium was conditioned (spent) by aerobic growth of ~- coli 
for 24 h at 37°C. The cultures were then centrifuged at low speed 
(setting 6, International Clinical Centrifuge, International Equipment 
Co.) to remove the bulk of bacteria and then filtered using a membrane 
filter (0.45 ~m pore size, Millipore Co.), for sterilization. 
B. Solid media. Enriched Trypticase soy agar (enriched TSA) 
was prepared by the addition of 1.5% agar (Difco Labs) to enriched 
TSB described above. Blood agar (5% defibrinated sheep blood) was 
obtained from BBL Laboratories. To examine the survival of B. fragilis 
at 4°C, Mueller-Hinton agar (BBL) and Schaedlers agar (BBL) supple-
mented with 0.05% hemin were used. In some cases, when a minimal 
medium for B. fragilis was required, TSA was used without supplementa-
tion. 
C. Selective media. To selectively isolate !· fragilis from 
E. coli in cultures containing both organisms, samples were plated on 
enriched TSA containing kanamycin (Sigma Chem. Co.) or streptomycin 
(Eli Lilly) to a final concentration of 100 ~g/ml. Aminoglycosides at 
this concentration were found to inhibit growth of ~- coli, while 
allowing growth of!· fragilis. To selectively isolate!· coli from 
mixed cultures containing !· fragilis, samples were plated on enriched 
TSA and incubated aerobically. 
D. Vitamins, cofactors and supplements. Bacto-peptone was 
supplemented with various compounds, alone or in combination, and the 
ability of !· fragilis to grow was then determined. Supplements added 
were: 0.05% hemin, 0.0005% menadione, vitamin B12 (Sigma Chem. Co.), 
ammonium sulfate, or a vitamin mixture (MEM-vitamin solution, lOOx, 
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Lot Cl233C, Grand Island Biological Co.). Several compounds were 
tested to determine their effect on the survival of !· fragilis at 
4°C in enriched TSB. For these experiments, various concentrations 
of magnesium chloride, sucrose (Merck and Co., Inc.), calf serum 
(Flow Labs, Inc.), or combinations of these materials were used. 
Unless the source of chemicals was specifically mentioned, reagent 
grade chemicals were used. 
III. Anaerobic system. 
Routinely, cultures were placed in anaerobe jars using the BBL 
Gas Pak system and incubated at 37°C. In some experiments, individual 
tubes or bottles were placed under anaerobic conditions by flushing 
with 10% co2 and 90% N2 (anaerobe grade, Benster Specialty Gas Co.) 
and tightly stoppered. Each bottle~ could then serve as an individual 
sample. Once the microenvironment of the bottle was disturbed by 
sampling, it was discarded. 
For experiments utilizing pus containing anaerobic bacteria, 
samples were placed in a chamber maintained under reduced conditions 
by flowing nitrogen gas (anaerobe grade, Benster Specialty Gas Co.). 
IV. Growth determinations. 
A. Turbidity. Turbidity of cultures was measured in a Klett-
Summerson colorimeter using a red number Sq filter. A standard 
curve of Klett units vs. viable cell number of !· fragilis .or !· coli 
was prepared. Using this information, an inoculum of known concentra-
tion could then be prepared for in vivo or in vitro experiments. 
B. Viable counts. Bacterial suspensions were appropriately 
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diluted in enriched TSB or steril~ distilled water and 0.1 ml was 
spread with a sterile bent glass rod on the surface of the appropriate 
agar medium. Cultures containing !· fragilis alone, or !· fragilis in 
mixed culture with ~· coli, were plated on enriched TSA containing 
100 J..lg kanamycin:~ or streptomycin/ml, and incubated at 37°C for 24-48 
h under anaerobic conditions. Cultures containing !· coli were plated 
in duplicate on enriched TSA and incubated at 37°C for 24 h under 
aerobic conditions. The number of colony forming units/ml of culture 
were then determined. 
V. Susceptibility of B. fra~ilis to oxygen and low temperature. 
A. Oxygen tolerance. To determine the ability of !· fragilis to 
survive exposure to atmospheric oxygen, approximately 100 cells were 
plated on enriched TSA and exposed to atmospheric oxygen at room tem-
perature. After various time periods of oxygen exposure, plates were 
incubated under anaerobic conditions at 37°C for 48 h and viable cell 
counts determined. 
B. Cold tolerance. For determination on solid media, !· fragilis 
was inoculated on enriched TSA plates to approximately 150 cells/ 
plate. Sets of inoculated plates in separate jars were placed at a 
specified temperature both under aerobic and anaerobic conditions. The 
anaerobic cultures were first incubated at 37°C for 1 h to obtain com-
plete anaerobiosis. At selected intervals, duplicate plates were 
removed from each set and incubated at 37°C anaerobically to determine 
the number of viable cells remaining. To test the effect of chilling 
on B. fragilis suspended in liquid media, 50 ml portions of enriched 
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TSB were dispensed into 60 ml dropping bottles. A sufficient number 
of bottles were prepared so that each bottle would only be sampled 
once before discarding. Bottles were stored overnight in an incubator 
at 37°C and then allowed to come to room temperature before use. 
Bottles to be used for anaerobic cultures were preincubated overnight 
at 37°C in a GasPak (BBL) anaerobe jar. Each bottle was inoculated 
with 0.5 ml of a diluted culture of !· fragilis to obtain a final 
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concentration of approximately 10 cells/ml. The anaerobic cultures 
were immediately flushed with 10% co2 + 90% N2 and tightly stoppered, 
while the aerobic cultures were covered with sterile aluminum foil. 
All bottles were then placed at the appropriate temperatures for 
various lengths of time and viability counts determined. 
The cold tolerance of microorganisms in pus collected from 
experimentally produced abscesses was determined as follows: Pus 
was pooled from a number of abscesses and thoroughly mixed while kept 
under anaerobic conditions. A series of tubes was prepared, each 
containing 0.1 g of pus. Tubes were flushed with anaerobic gas and 
then divided into three sets. One set was placed at room temperature 
and the second set at 4°C and the third set at l5°C. Another three 
sets of tubes were flushed with air. Again, one set was placed at 
room temperature and the others at 4°C and l5°C. All tubes were 
tightly sealed to avoid desiccation. Duplicate sample tubes were 
removed from each set at designated time periods and again weighed. 
Five ml of saline (0.85% NaCl) were added to each tube, the tubes 
mixed thoroughly, and viable counts were determined as a number of 
organisms/g of pus. 
p 
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VI. Int.eraction of B. fragilis and E. coli in vitro. 
A. Effect of E. coli growth on the growth of B. fragilis. The 
kinetics of growth of !· fragilis and E. coli in a mixed culture were 
first determined. !· coli and B. fragilis each at a concentration of 
105 cells/ml were inoculated to enriched TSB. At various times during 
incubation, samples were removed, appropriately diluted in sterile 
saline, and 0.1 ml was plated on solid media. Number of E. coli was 
determined by plating samples on enriched TSA and incubating aerobic-
ally. The number of B. fragilis was determined by plating samples on 
enriched TSA containing 100 ~g kanamycin/ml and incubated anaerobic-
ally. Colony counts were performed 24 h .later after incubation at 
To test the effect of the initial concentration of E. coli on 
B. fragilis growth, the inoculum size of E. coli was varied from 101 
cells/ml to 103 cells/ml. Viable counts of each were determined at 
designated intervals. 
To determine the effect of selective inhibition of E. coli on 
---
the growth of !· fragilis in mixed culture, kanamycin was added to 
the mixed cultures at designated time intervals. Kanamycin was 
added to a final concentration of 100 ~g/ml. Samples were taken at 
designated times and viable counts were then determined as previously 
described. 
Since our preliminary experiments showed that growth of !· fra-
gilis was enhanced when. it was incubated with E. coli, an experiment 
was devised to determine if cell to cell contact was necessary for 
this interaction. B. fragilis and E. coli were physically separated 
, 
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by a dialysis membrane. Dialysis tubing containing 50 ml of peptone 
was placed into a flask containing 100 ml of the same medium. Using 
a bent glass tube, the medium inside of the dialysis tubing was ino-
culated with E. coli. Medium outside the dialysis tubing was inocu-
lated with~· fragilis. The flask was then placed aerobically at 
37°C and growth of B. fragilis observed after 24 h and 48 h. 
B. Effect of other organisms on B. fragilis growth. E. coli 
was replaced by 105 cells/ml of Klebsiella ~neumoniae or Proteus 
vulgaris in mixed culture growth. Ability to stimulate ~· fragilis 
growth was then determined at 24 h and 48 h as previously described. 
C. Effect of conditioned medium on growth of B. fragilis. The 
~bility of E. coli conditioned peptone and semi-synthetic medium to 
stimulate growth of ~· fragilis was determined by two methods and 
stimulatory factors then further characterized in conditioned semi-
synthetic medium. 
1. Test in liquid medium. Various amounts of !· coli spent 
medium, ranging from 0 to 50 ml, were added to 50 ml of stored medium. 
The volume of medium in each tube was brought to 10 ml with sterile 
saline. All tubes were inoculated with 105 cells B. fragilis/ml, and 
incubated anaerobically at 37°C·for 24 h. 
2. Test on solid medium. The growth stimulatory activity 
of spent media for B. fragilis was determined on solid media as 
follows. The surface of TSA or enriched TSA was spread with approxi-
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mately 10 cells of~· fragilis. Wells, 6.5 mm in diameter, were 
cut with a metal ff5 cork borer and then filled with 0.25 ml of con-
ditioned peptone or semi-synthetic media. Plates were incubated at 
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37°C under anaerobic conditions for 4~ h. Stimulation was defined as 
an enhanced growth around wells when compared to control wells con-
taining saline or distilled water. 
3. Characterization of B. fragilis stimulatory factors 
produced by E. coli. The stability of the stimulatory factors under 
various conditions was determined by treating separate samples of 
!· coli spent semi-synthetic medium in a variety of ways. Spent 
medium was placed in a boiling water bath for 30 min and then cooled 
to room temperature. Other samples were either (a) adjusted to pH 
2.0 with HCl (Baker Chem. Co.), placed at room temperature for 1 h, 
and then neutralized with NaOH, or (b) adjusted to pH 12.0 with NaOH, 
placed at room temperature for 1 h, and then neutralized with HCl. 
After determining stability of the stimulatory materials to 
heat:,acid,and alkali, their physical and chemical properties were 
further characterized. Spent medium was dialyzed extensively against 
distilled water to determine if the stimulatory materials were macro-
molecular, or relatively small molecules. Cation exchange resin (Cl-
charged, Dowex 50 W, 100-200 mesh, Sigma Chem. Co.), or anion ex-
change resin (ff+ charged, Dowex 1-XS, 100-200 mesh, Sigma Chern. Co.) 
was used to remove negatively charged or positively charged materials 
respectively. Activated charcoal (Norit A, Baker Chern. Co.) was 
used nonspecifically to remove certain substances. To determine if 
the stimulatory materials were lipid in composition, spent medium 
was extracted with ether (Mallincrodt, Inc.). All treated spent 
media was then qualitatively assayed for stimulatory activity using 
the solid medium assay ~s described above. 
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VII. Antibiotic susceptibility. 
Susceptibility of ~· fragilis and !· coli to cephalothin (Keflin, 
Eli Lilly), cephalexin (Eli Lilly), cefazolin (Eli Lilly), cephalori-
dine (Eli Lilly), cefamandole (Eli Lilly), penicillin (Sigm Chem. Co.), 
kanamycin (Sigma Chern. Co.), gentamicin (Schering), streptomycin (Eli 
Lilly), and erythromycin (Sigma Chern. Co.) was determined and express-
ed as minimal inhibitory concentration (MIC). 
Organisms grown anaerobically in enriched TSB for 24 h at 37°C 
were diluted 1 to 100 into enriched TSB, and used as the inoculum. 
This inoculum contained an average of 100 organisms/ml as determined 
by viable cell counts. The antibiotics were diluted in sterile dis-
tilled water and 0.5 ml of each antibiotic dilution plus 0.5 ml of 
inoculum were added to 9.0 ml of enriched TSB to obtain final concen-
trations ranging from 0.39 to 1,000 ~g of antibiotic/ml. The tubes 
were incubated at 37°C for 24 h in a GasPak system. The first tube 
showing no turbidity was taken as the end point of the minimal 
inhibitory concentration (MIC). 
VIII. Measurement of dissolved oxygen. 
The dissolved oxygen level in broth media was measured using a 
model 53 oxygen monitor equipped with a Clark oxygen electrode (Yellow 
Springs Instrument Co.). Measurements were obtained as percent of 
total saturation of the medium with oxygen (saturation produced by 
extensive vortexing). In accord with the studies of Morris (1975), 
the oxygen content of broth media for bacterial growth was accepted 
as 250 pmoles oxygen/! at saturation. Oxygen concentration of broth 
media in this study was calculat~d as follows: 
~moles oxygen/! in = % saturation x 250 ~moles/1 
test medium 
IX. Preparation of superoxide dismutase (SOD) and its effect on 
!· fragilis. 
Superoxide dismutase was prepared from bovine blood (Lincoln 
Slaughter House, Chicago, Ill.). Red blood cells (RBC's) were 
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separated from 2 liters of citrated whole blood by centrifugation for 
12 min at 4,000 g (Model B-20, International Equipment Co.) and 
washed twice in saline. 
The red cells were lysed by diluting them 1:1 in distilled 
deionized water. Hemoglobin was then precipitated and the superoxide 
dismutase was prepared by the procedure of McCord and Fridovich 
(1969). 
To determine superoxide dismutase activity, a nitro blue tetra-
zolium (NBT) assay was used (Beauchamp & Fridovich, 1971). This 
assay is based on the use of xanthine oxidase to catalyze the oxida-
tion of xanthine, resulting in the generation of superoxide radicals. 
NBT intercepts the radicals and becomes oxidized, resulting in an 
increase in absorbance at 560 nm. The reaction mixture consisted of 
0.3 ml 2.2 x 10-8 N xanthine oxidase (Sigma), 1 x lo-3 N xanthine, 
0.3 ml 2.5 x 10-4 N NBT (Sigma), 0.3 ml 1 x lo-3 N ethylenediamine 
tetraacetic acid (EDTA), 0.3 ml 0.5 N sodium carbonate, 0.3 ml of 
enzyme and 1.2 distilled water. One unit of superoxide dismutase is 
defined as the amount necessary to produce 50% inhibition of the rate 
of reduction of NBT by xanthine oxidase. The extracted SOD was found 
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to have .an activity of 6.5 units/ml. After determining the SOD acti-
vity, the crude extract was added in varying concentrations to Bacto-
peptone medium to test the effect of its presence on the growth of 
B. fragilis. 
X. Experimental intra-abdominal abscess formation in rats. 
A. Animals. Female white rats (outbred Sprague-Dawley albino, 
Scientific Small Animal Laboratory and Farm, Inc., Arlington Heights, 
Ill.) ranging from 250 to 300 g in weight were used in the present 
investigation. Animals were placed 5 per cage before and following 
the surgical procedures and were maintained on Purina Rat Chow (Ral-
ston Purina, St. Louis, Mo.) and water ad libidum. 
B. Preparation of implants. Two types of implants were used to 
introduce microorganisms into ~he abdominal cavity while minimizing 
their diffusion. These were: a) an artificial fecal material impreg-
nated with a bacterial inoculum, or b) a plasma or blood clot impreg-
nated with a bacterial inoculum. Artificial fecal material was pre-
pared by adding equal quantities of minced beef (80% lean hamburger, 
Jewel Food Stores) to cellulose fiber (\fuatman filter paper, #1, W. & 
R. Balston, Limited). Filter paper had been broken into cellulose 
fiber by mixing extensively in an Omni-Mixer (Sorvall, Inc.). A small 
piece (0.35-0.4 g wet weight) of autoclaved artificial fecal material 
was placed inside a #0 gelatin capsule which was then inserted into a 
#1 gelatin capsule. Gelatin capsules (Eli Lilly & Co.) had been 
sterilized by exposure to UV light (20 em from a Westinghouse Steri-
lamp 782L-20) for 48 h prior to use. Cultures were grown for 18 to 
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24 h in .enriched TSB and diluted to the desired concentration. 
Immediately before implantation into animals, a predetermined number 
.. 
~. of organisms was impregnated into the artificial fecal material. 
Plasma or blood clots were prepared as follows: male and 
female rats (Locke-Erickson Co.), 400-500 gin weight, were bled by 
cardiac puncture using 10 ml syringes that had been flushed with 
heparin solution (Lipo-Hepin, 5000 units/ml, Upjohn Co.). After 
collection, the blood was placed into 0.7 ml red top Vacutainer 
tubes containing Lipo-Hepin (Upjohn Co.). The heparinized blood was 
centrifuged to remove red blood cells, and the plasma then sterilized 
by filtration through membrane filters (0,45 ~m pore size, Millipore 
Corp.). Immediately before surgery 1.0 ml of plasma was distributed 
to each of the several tubes. To prevent fibrinolysis 0.05 ml of 
aminocaproic acid (Amicar, Lederle) was added to each tube. The 
plasma was inoculated with 0.1 ml of a bacterial suspension after 
which 0.3 ml of thrombin (Parke-Davis, 5000 units/25 ml) was added 
to initiate clot formation. A firm clot formed within 30 seconds 
that exhibited little, if any, fibrinolysis and clot retraction. If 
a blood clot was desired rather than a plasma clot, red cells were not 
removed. 
C. Rat abdominal surgery. Rats were anesthetized by intra-
muscular injection of 0.07 ml Innovar (fentanyl plus droperidol, Pit-
man-Moore, Inc.) •. The abdomen of each rat was then shaved and the 
skin disinfected with 70% ethanol. A 1.5-2.0 em incision was made on 
the posterior midline through the abdominal wall and into the peri-
toneum so as to form an artificial capsule around the inoculum with 
r--
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mesentery and intestine. The peritoneum was closed with 4 or 5 con-
tinuous sutures of 3-0 monofilament (Ethilon, Ethicon Co.). 
D. Evaluation of abscess formation. An abscess was defined as a 
circumscribed collection of pus. Carefully isolated abscesses were 
removed on day 42 and weighed. Smears of pus were prepared for light 
microscopic examination. Viable counts of B. fragilis and/or !· coli 
from washings of the peritoneal cavity and of pus from the abscesses 
were determined as previously described. 
Animals that had been implanted with plasma clots or blood clots 
were necropsied at 3 h, 6 h, 12 h, 24 h, 3 days, 7 days or 14 days. 
Presence or absence of abscesses, as well as general appearance of the 
animals, was noted. 
E. Histologic examination of intraperitoneal abscesses. Animals 
were necropsied at 1 day, 3 days, 7 days and 12 days after irnplanta-
tion of the artificial fecal material. Histologic exaflination was 
performed both on the abscesses and on tissues immediately surround-
ing the site of implantation. 
Immediately after necropsy, tissues for histology were fixed in 
buffered formalin (pH 7.2) for 48 h, embedded in paraffin, sectioned, 
and stained with either hematoxylin-eosin (H and E) or phosphotung-
stic acid hematoxylin (PTAH). 
XI. Light microscopy and photomicrography. 
All light microscopy was performed with a Nikon light microscope 
fitted with both phase contrast and plain objectives. Photomicro-
graphs were made on panchromatic film (Plus-X, Kodak) with a Nikon 
camera equipped with an automatic exposure system attached to the 
microscope. Film was developed with Microdol developer (Kodak). 
XII. Analysis of data. 
Determination of the statistical significance of differences 
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was made by using a Student's t test. For comparing percent survival 
of !· fragilis and E. coli in pus after exposure to oxygen or low 
temperature, and for analyzing differences in weight of intra-abdomi-
nal abscesses produced in rats, data were expressed as mean± standard 
error of the designated number of values. For comparing percent sur-
vival of !· fragilis and E. coli after in vitro exposure to oxygen or 
low temperature, data was expressed as mean + standard deviation of 
the designated number of values. A difference was considered statis-
tically significant if the p value was less than 0.05. 
RESULTS 
I. Characterization of B. ~ilis used in this investigation. 
Prior to actual experimentation with B. fragilis, its growth 
characteristics, antibiotic sensitivity patterns, and susceptibility 
/ 
to oxygen and low temperature were examined. This was necessary 
because the strain of ]!:> fra~ilis used (strain 8044) was a clinical 
isolate which had not been previously characterized. 
A. Growth of B. fragilis in enriched TSB. In order to stan-
dardize inoculum for in vitro and in vivo experiments, the time course 
of growth of ~· fragilis in enriched TSB and the relationship of cul-
ture turbidity to viable cell number were determined. 
A typical growth curve of~· fragilis, obtained by the method 
described in Materials and Methods, is shown in Fig. 1. Since the 
relationship between Klett unit reading and viable cell number (24 h 
9 
cultures) held a linear correlation up to 10 cells/ml (200 Klett 
units), an exact number of~· fragilis cells could be readily deter-
mined for inoculation purposes. 
B. Antibiotic susceptibility of ~· fragilis. The susceptibility 
of B. fragilis strain 8044 to various antibiotics is summarized in 
Table 1. This antibiogram was used for preparation of a medium that 
would be selective for B. fragilis when mixed cultures of B. fragilis 
and E. coli were studied. 
Of all the cephalosporin derivatives tested, ~· fragilis was most 
susceptible to cephazolin, with a minimal inhibitory concentration 
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Fig. 1. Representative growth curve of~· fragilis in enriched TSB at 
37°C. Each point represents the mean viable count of duplicate 
samples as described in Materials and Methods. 
_...4 
33 
• 
E 
......... 
(/) 
_. 
_. 
lJJ 
u 
lJJ 108 
_. 
CD 
<( 
-> 
107~--~--~--~--~--~--~--'~--··~ 6 8 10 24 
TIME ( hr) 
TABLE 1. 
MICa of various antibiotics for B. fragilis and E. coli 
MIC (JJg/ml) for 
Antibiotic B. fragilis 
subsp. fragilis E. coli 
Cephalothin 12.5 25 
Cephalexin 12.5 25 
Cefazolin 3.12 3.12 
Cephaloridine 6.25 6.25 
Cefamandole 6.25 NDb 
Penicillin G 6.25 3.12 
Kanamycin > 1000 3.12 
Gentamicin > 1000 12.5;...25 
Erythromycin < 1.56 3.12 
aMinimal inhibitory concentration (MIC) determined by 
the broth dilution technique described in Materials 
and Methods. 
b ND = not done. 
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(MIC) of 3.12 ~g/ml (Table 1). !· fragilis was also susceptible to 
quite low levels of erythromycin with an MIC of < 1.56 ~g/ml. B. fra-
gilis was not susceptible to any aminoglycoside tested, even at levels 
of > 1000 ~g/ml, confirming earlier reports (Finegold and Sutter, 
1971; Martinet al., 1972). 
C. Survival of B. fragilis after storage in atmospheric o~ygen. 
During the collection, transportation, storage and handling of clinical 
specimens containing anaerobic bacteria, some exposure to atmospheric 
oxygen is unavoidable. In order to determine whether !· fragilis 
might be inactivated under our experimental conditions, sensitivity of 
B. fragilis to atmospheric oxygen was determined. 
During 24 h of oxygen exposure, essentially no !· fragilis via-
bility was lost (Fig. 2). Even after 72 h, only 2-3% viability was 
lost. This information indicates that handling and manipulation of 
our B. fragilis strain can be undertaken on the bench under aerobic 
conditions. 
D. Survival of B. fragilis after storage at low temperature. 
In some cases during our investigation, mixed cultures containing 
B. fragilis might be stored at low temperature to avoid the overgrowth 
of coexistent facultative bacteria. Finegold et al. (1974) recom-
mended that if specimens had to be stored for longer than 2 h, they 
should be refrigerated to avoid this type of overgrowth. However, 
other investigators (Dowell and Hawkins, 1974; Finegold et al., 1974), 
reported that low temperature was lethal for anaerobic bacteria and 
that these organisms should not be stored in the cold. To resolve 
this controversy and to determine whether our experimental conditions 
Fig. 2. Survival of~· fragilis after exposure to atmospheric oxygen 
and low temperature. Predetermined numbers of 18 h old B. 
fragilis cells were plated in duplicate on enriched TSA (o-o), 
or suspended in enriched TSB (~-~), and then exposed to 
chilling (4°C) for specified periods under aerobic conditions. 
The number of surviving cells after exposure to 4°C was 
determined as described in Materials and Methods. Duplicate 
sets of inoculated plates (enriched TSA) were left at 25°C 
(•-•) under aerobic conditions. 
____...,... 
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might cause a loss in viability of !· fragilis, sensitivity of !· fra-
gilis to low temperature was determined. Results of this experiment 
can be seen in Fig. 2 and 3. !· fragilis was killed rapidly at 4°C, 
but there was essentially no loss of viability at 25°C. A similar 
loss in viability at 4°C was observed when!· fragilis was plated on 
enriched Mueller-Hinton Agar, enriched Schaedler's agar, or blood 
agar (Fig. 3). Although data are not shown here, other strains (8268, 
7728, 6880 and 2701) of B. fragilis exhibited a similar sensitivity to 
low temperature. 
The effect of chilling on!· fragilis in liquid medium was also 
tested. Over 50% viability was lost within the first 12 h after which 
the rate of loss slowed until a loss of 80% viability was demonstrated 
at 72 h (Fig. 2). 
In order to clarify whether this inactivation of B. fragilis at 
4°C was due to the lethal effect of a higher oxygen concentration 
dissolved in the cold media, or due to injuries induced by cold, we 
determined the loss of viability of B. fragilis exposed to low temper-
ature (4°C) under both aerobic and anaerobic conditions. It appears 
. 
that the inactivation of !· fragilis was a result of cold injury since 
loss of viability occurred at 4°C either in the presence or absence of 
oxygen (Fig. 4). Under aerobic conditions, cells suspended in liquid 
media (Fig. 4B) appeared to be more susceptible (p < 0.005) to cold 
than those plated on solid media (Fig. 4A). However, under anaerobic 
conditions there seemed to be no significant difference in the extent 
of killing of B. fragilis between solid and liquid media. 
To determine if the ability to survive prolonged exposure to low 
• 
Fig. 3. Survival of B. fragilis after exposure to low temperature. Pre-
determined numbers of 18 h old cells were plated in duplicate on 
various solid media. and exposed to 4°C and 25°C for a specified 
time under aerobic conditions, and the numbers of surviving 
cells were determined as described in Materials and Methods. 
Symbols: ,-,, enriched Mueller-Hinton Agar; x-x, enriched 
Schaedler's Agar; o-o, enriched TSA; 6-6, commercial blood agar. 
Solid lines represent the exposure at 4°C and the dotted line 
represents the exposure at 25°C. 
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Fig. 4. Survival of~· fragilis after storage of fresh isolates at low ~ Aerobic condition 
~ Anaerobic condition 
temperature. Predetermined numbers of cells were either sus-
pended in enriched TSA (A), or plated on enriched TSB (B) and 100 A 100 8 
exposed to 4°C both under aerobic and anaerobic conditions for 
12 h and the numbers of surviving cells were determined as 
described in Materials and Methods. The controls refer to 
the number of ~· fragilis cells inoculated at time 0. Mean 
and standard deviation of at least 3 values are indicated in 
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temperature differed between cells in exponential phase (6 h) and 
stationary phase (18 h), cultures of both ages were exposed to low 
temperature (Fig. 5). Under all conditions tested, older cultures 
(18 h) were more susceptible to chilling than younger cultures (6 h). 
Tally et al. (1975) noted that repeated subculturing of !· fragilis 
might reduce its susceptibility to oxygen. To examine this possibil-
ity, the decrease in susceptibility of !· fragilis (18 h culture) to 
chilling after repeated transfers on blood agar medium was determined 
(Fig. 6). !· fragilis cells transferred on blood agar more than 15 
times became significantly (p < 0.05) more tolerant to cold than the 
fresh isolate. 
In attempting to minimize the lethal effect of low temperature 
on B. fragilis, various materials were added to enriched TSB before 
storage of~- fragilis (Table 2). The detrimental effect of chilling 
on~- fragilis was minimized when 5 mM magnesium chloride and 1.0 M 
sucrose were added. Calf serum or divalent cations alone added to the 
enriched TSB did not protect ~- fragilis from the lethal effect of low 
temperature. 
From the above data, it is obvious that long periods of exposure 
to low temperature are lethal to !· fragilis under most conditions 
tested, and that storage of this organism at low temperature should be 
avoided. 
E. Survival. of B. fragilis in experimentally produced pus. To 
determine whether B. fragilis cells in pus were similarly affected by 
low temperature, pus containing!· fragilis, !·coli, or mixed cultures 
of both organisms, was collected from experimental animals and tested. 
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Fig. 5. Survival of exponentially growing and stationary phase~· fragilis. 
after storage at low temperature. Predetermined numbers of 6 h 
and 18 h and old ~· fragilis (freshly isolated) were either 
on enriched TSA (A and B) or suspended in enriched TSB (C and D) 
and exposed at 4°C for 12 h, either under aerobic conditions (A 
and C), or anaerobic conditions (Band D). The numbers of sur-
viving cells were determined as described in Materials and Methods 
The controls represent the number of ~· fragilis cells inoculated 
at time 0. Mean and standard deviation of at least 3 values are 
indicated on each bar. 
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Fig. 6. Survival of subcultured ~· fragilis after storage at low 
temperature. Predetermined numbers of either freshly isolated 
or repeatedly subcultured 1!· fragilis (both •.rere 18 h cultures) 
were plated on enriched TSA (A and B), or inoculated in en-
riched TSB (C and D), and exposed at 4°C both under aerobic 
(A and C) and anaerobic (B and D) conditions. The number of 
surviving cells after 12 h of exposure was determined as 
described in Materials and Methods. The controls represent 
the number of cells inoculated at time 0 (approximately 1 x 105 
cell/ml final concentration). Mean and standard deviation of at 
least 3 values are shown on each bar. 
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TABLE 2. 
Effect of selected compounds on the survival of 
B. fragilis at 4°C in enriched TSBa 
None 
Stored in 
enriched TSB 
plus: 
1 mM MgC12 
5 mM MgC12 
10 mM MgC12 
5 mM CaC12 
5 mM MgC12 + 0.1 M Sucrose 
5 mM MgC1 2 + 0.5 M Sucrose 
5 mM CaC12 + 1.0 M Sucrose 
5 mM Cac12 + 0.5 M Sucrose 
10% Calf serum 
20% Calf serum 
50% Calf serum 
% Survival 
after 12 h 
10 
4 
13 
6 
9 
11 
48 
97 
30 
8 
9 
11 
aTrypticase soy broth containing yeast 
extract (0.5%), hemin (0.05%), and 
menadione (0.0005%). 
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Percent of survival of B. fragilis in pus, in which !· fragilis was the 
only infectious agent, is shown in Fig. 7A and B. B. fragilis in the 
pus lost viability slowly but progressively at 4°C whether it was 
stored under aerobic or anaerobic conditions. However, when it was 
stored at 25°C, no significant loss of viability occurred within 24 h 
under both aerobic and anaerobic conditions. Since most anaerobic 
infections are mixed infections containing both strict and facultative 
anaerobes, we investigated the survival of !· fragilis and !· coli in 
pus in which both microorganisms coexisted. The results of these 
experiments are summarized in Fig. 8. While the survival pattern of 
!· fragilis in such pus (Fig. SA and 8C) was similar to that seen 
above (Fig. 7A and 7B), there was a significant increase in number of 
!· coli when pus was stored at 35°C (Fig. 8B and 8D). Apparently, 
chilling was also detrimental to E. coli whether pus was stored under 
aerobic or anaerobic conditions. In an effort to find an alternative 
condition for storage of pus that allows the maximum number of B. 
fragilis to survive while suppressing the overgrowth of coexistent 
E. coli, we tested the survival of both organisms in pus stored at l5°C. 
The results of such an experiment are summarized in Table 3. It is 
apparent that, at this temperature, most !· fragilis remained viable 
for at least 24 h while the overgrowth of coexistent E. coli was 
minimized. 
F. Preliminary animal experiments. In an attempt to establish 
an intra-abdominal abscess model suitable for studying the interaction 
between B. fragilis and!· coli in vivo, several preliminary experi-
ments were performed. 
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produced intraperitoneal abscesses in rats. Samples of pus 
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Fig. 8. Survival of !· fragilis and !· ~ in pus after storage at 
25°C or 4°C. Pus containing !· fragilis and !· ~was 
collected from experimentally produced intraperitoneal abscesses 
in rats. Samples of pus were placed under aerobic (A and B) or 
anaerobic (C and D) conditions at 25°C (•-•) or 4°C (o-o) for 
varying lengths of time. Number of surviving cells was de-
termined as described in Materials and Methods. Points and 
bars represent mean±. standard error of at least three values. 
Absence of a bar indicates that the standard error is smaller 
than the area covered by the point itself. 
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TABLE 3. 
Change in viable cell number of !· fra~ilis and !• coli in pus at 15°C, 
, .. ,; .~
%of original inoculum+ S.E.a 
Time (h) of _!!. fragilis _!!. fragilis 
storage (monoinfection) (mixed infection) 
aerobicb anaerobic c aerobicb anaerobicc 
0 100 + 3d 100 + 3 100 + 2 100 + 2 
2 84 + 6 116 + 8 86 + 6 66 + 9 
24 76 + 13 87 + 5 94 + 11 73 + 3 
aStandard error 
bstored aerobically 
cStored anaerobically 
d Each figure represents the mean of at least three samples 
E. coli 
(mixed infection) 
aerobic b anaerobicc 
100 + 10 100 + 10 
106 + 6 86 + 9 
129 + 30 130 + 7 
~ 
" 
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1. I~.1oculation of bacterial suspensions. Rats (5 per group) 
were implanted with gelatin capsules containing a suspension of 108 
cells~- fragilis or 108 cells ~· fragilis plus 108 cells E. coli. By 
24 h, a lethal peritonitis had resulted in 100% mortality of animals 
implanted with~· fragilis and!· coli. On necropsy, intraperitoneal 
abscesses could not be detected (Fig. 9C). No mortality was observed 
by 15 din animals implanted with~· fragilis alone (Fig. 9A). Repre-
sentative animals from this group were necropsied at 4 d, 8 d, or 15 
d. Peritonitis could not be detected at any time, and intraperitoneal 
abscesses did not form. 
This model is not suitable for our studies because of the lack 
of formation of intraperitoneal abscesses. Abscesses probably did not 
form because of the rapid diffusion of microorganisms from the area of 
implantation. 
2. Implantation of rat fecal material. Intraperitoneal 
abscesses often result from some type of trauma or surgery that causes 
spillage of colonic contents. Rats (5 animals) were implanted with 
gelatin capsules containing rat fecal material as described previously 
by Deysine et al. (1967). As seen with the previous model, allanimals 
formed well defined abscesses (Fig. 9B), and lived until necropsy at 
15 d. 
Although this model is effective in causing anaerobic intra-
abdominal abscesses, several problems make it unsuitable for a criti-
cal study of such infections. These include the undefined nature of 
feces, the multiplicity of bacterial species, and also the bacterial 
end products that lend to the complexity of this system. 
Fig. 9. Rats infected with~· fragilis, ~· fragilis in combination 
with~· coli, or with rat fecal material. Animals (5 rats 
per group) were implanted with a single gelatin capsule 
containing (A) 108 cells of ~· fragilis, (B) fresh rat fecal 
material, or (C) 108 cells of ~· fragilis and 108 cells of 
~- co1i . A11 a nima 1 s in group C were dead b y 24 h. Anima 1 s 
1nf ected w1th ~· frag111s a1one or rat feca1 mater1a1 were 
necropsied on day 15. As designated by the arrow in B, 
abscesses were reproducibly formed in animals infected with 
the fecal material. 
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3. Implantation of bacteria impregnated in "artificial feces." 
To avoid the problems of using actual fecal material to cause 
abscesses, an artificial feces was developed. This was defined as a 
mixture of sterile ground meat and cellulose fiber, into which a known 
bacterial inoculum had been impregnated. The artificial feces was 
then placed into a gelatin capsule and implanted in the peritoneal 
cavities of rats. 
I 
Intra-abdominal abscesses were formed when the artificial fecal 
material contained certain bacteria or bacterial mixtures. The ulti-
mate size ~f these abscesses depended on the types of bacteria which 
had been impregnated into the sterile meat and cellulose. 
It is obvious from these results that it is possible to utilize 
the basic model of Deysine et al. (196 7) to cause intraperitoneal 
abscesses while retaining the ability to carefully define the inocu-
lum size and composition implanted into rats. For this reason, the 
artificial feces model of intra-abdominal abscess formation was adopt-
ed for our studies. 
II. Interaction between B. fragilis and E. coli in vivo. 
A. Enhancement of B. fragilis pathogenicity by E. coli. The rat 
intra-abdominal abscess model developed by Deysine et a1. (1967) and 
used by Weinstein et a!. (1974) was modified (see Materials and Methods) 
to determine whether the pathogenicity of !· fragilis could be enhanced 
by!· coli. The results of the experiments using the modified animal 
model are summarized in Table 4. 
When gelatin capsules, containing artificial fecal material 
impregnated with B. fragilis alone, !· coli alone, or the combination 
:~ 
TABLE 4. 
Average weight and bacteriological data 
of abscesses experimentally produced in rats 
Organisms impregnated 
in artificial fecal 
Organisms recovered from 
a Group material 
Weight of encap-
sulated material 
(g) 
Frequency of 
abscess 
formation (%) peritoneal cavity pus (cells/g) 
1 No bacteria 0.69 + 0.22 b oc Sterile Sterile 
2 !· !§agilisd 0.73 + 0.40 100 Sterile B. fragilis 
(10 cells) -3.2 X 109 
3 e 2.80 + 1. 22 100 Sterile !· coli 8 !· Egli (10 cells) 3.85 X 10 
4 B. fragilis 4.04 + 1.69 100 Sterile B. fragilis 
- (108 cells) -6.5 X 109 
and and 
E. coli !· coli 9 
-(100Cells) 1. 7 X 10 
a 10 animals were used for each group. 
b Mean + standard deviation. 
c Since only sterile artificial fecal material was found within the encapsulation, we did not con-
sider these as abscesses. 
d The Ln50 of!· fragilis for rats could not be determined with an inoculum of as high as 10
10 
cells. 
None of the animals had died at 42 days and abscesses were minute in size with all doses of !· fra-
gilis used. 
e 8 ThP. LD50 of!· coli for rats was 1.15 x 10 cells. All surviving 109 !· coli exhibited large intraperitoneal abscesses at 42 days. 
E. coli died within the 42 days of observation. 
5 
animals from groups given 10 to 
None of the animals given 106 
IJ1 
1-' 
-w~ 
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of both organisms, were implanted into the peritoneal cavities, various 
sizes of abscesses were formed intra-abdominally in 42 days (Table 4). 
Implantation of capsules containing artificial feces alone resulted in 
encapsulation of the inoculum without the marked accumulation of pus. 
Representative photographs of rats from each experimental group are 
shown in Fig. 10. 8 When 10 cells of B. fragilis were added to the 
artificial fecal base and implanted into the peritoneal cavity, only 
small intra-abdominal abscesses were formed (Fig. lOB). The average 
weight of~· fragilis induced abscesses was 0.73 g ± 0.40, not signi-
r ficantly larger than the encapsulated granule produced by the sterile 
, 
~·· artificial fecal inoculum (0.69 g + 0.22). However, ~· fragilis in 
' 
pure culture was isolated at 3.2 x 109 cells per gram of pus. When 
6 10 cells of ~. coli were added to the artificial fecal base and 
implanted into animals, large abscesses (2.80 g ± 1.22) were formed 
(Fig. lOC) which were significantly larger than the control group 
(p < 0.001). The abscesses produced by E. coli contained larger 
quantities of pus than abscesses caused by ~· fragilis and were shown 
8 to contain 3.85 x 10 cells of viable !· coli per gram of pus (Table 
8 6 4). When 10 cells of!· fragilis and 10 cells of E. coli were com-
bined and implanted into animals (Fig. lOD), the resultant abscesses 
(4.04 g ± 1.69) were significantly larger than the control (p < 0.001) 
or those formed by!· fragilis alone (p < 0.001), although they were 
not significantly different from those produced by !· coli alone (p < 
0.10). Abscesses produced by the combination of both organisms were 
filled with pus that contained both viable E. coli and !· fragilis 
(1.7 x 109 and 6.5 x 109 cells/g pus, respectively). In all cases, 
. ~ 
·. 
· .. 
Fig. 10 . Intra -abdom~nal abscess formed in rats by!· coli or 
~· fragili s or by the combination of both organisms. 
Animals (10 rats per group) were implanted with a 
double gelatin capsule containing artificial feces 
impregnated with (A) no bacteria (control), (B) 108 
B. fragilis cells, (C) 106 !· coli cells , or (D) 108 
B. fragilis cells combined . 6 w~th 10 E. coli cells . 
Arrows indicate the encapsulated sterile feces in 
Fig. lA, and the abscesses (Fig. lB to lD) formed in 
rats as specified above. 
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the periconeal cavity of the rats was sterile at the time of necropsy. 
Both ~. fragilis and ~· coli alone caused the formation of intra-
peritoneal abscesses in rats. The combination of these organisms 
caused abscesses that appeared larger than those caused by either 
alone, although they were not statistically different in weight from 
C' those induced by E. coli. These results are significantly different 
:~: 
from those reported by Onderdonk et al. (1976) in that!· fragilis and 
!· coli could independently cause intraperitoneal abscesses to form. 
To our knowledge, this is the first demonstration of intraperitoneal 
abscesses caused by a facultative anaerobe alone. Onderdonk et al. 
(1976)-reported that neither organism could cause abscesses unless the 
other was present. 
B. Lethality of B. fragilis and E. coli for the rat. In order 
to determine the maximum number of E. coli or B. fragilis that could 
be implanted in the rat to cause abscess formation without causing 
lethality, the tn50 of each organism was determined. 
!· fragilis in concentrations ranging from 105 to 1010 cells/ml 
was impregnated in artificial fecal material and implanted into the 
peritoneal cavity of rats. The tn50 of !· fragilis in this model 
10 
system could not be determined with an inoculum as high as 10 cells. 
None of the animals had died by 42 days postoperatively. 
E. coli in concentrations ranging from 105 to 1010 cells/ml was 
also impregnated into artificial fecal material and implanted in rats. 
The LD50 of !· coli for rats in this model system was found to be 1.15 
x 108 cells. 
On the basis of these findings, an inoculum of 108 cells B. fra-
r 
' 
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gilis, 106 cells~· coli, or the combination of both organisms was 
used in our animal model of anaerobic infection. 
C. Histology of experimentally produced abscess. The histo-
logic examination of abscesses caused by !· fragilis, !· coli or the 
combination of both, was performed. A typical cross section through 
an abscess formed by implantation of gelatin capsules containing 
artificial fecal material impregnated by !· fragilis and E. coli is 
shown in Fig. 11. 
The outside of the abscess is seen to the right of the micro-
graph. In the older, outermost area of the abscess wall, granulation 
tissue (GT) and proliferation were evident with fibrosis extending to 
the surrounding adipose tissue (A). Closer to the lumen of the 
abscess, (L) there were increasing numbers of phagocytic cells (P). 
Plasma cells and macrophages were more prominent in this area. In 
the lumen of the abscess was a large amount of exudate, primarily 
debris, bacteria and polymorphonuclear leukocytes. This histopatho-
logic description is also typical for abscesses sectioned from human 
tissues. There was no difference in histologic appearance of this 
abscess and those caused by !· fragilis alone or E. coli alone when 
animals were necropsied at 42 d. 
Since differences in response to these organisms might be more 
visible at an earlier time after implantation, tissue surrounding the 
gelatin capsule and artificial fecal material was observed histologi-
cally at 1 d, 3 d, and 7 d postoperatively. At 24 h after implanta-
tion, tissue surrounding the abscess caused by !· fragilis or the 
combination of B. fragilis and E. coli was found to have microthrombi 
Fig. 11. Cross section of an intra peritoneal abscess formed in rats by 
implantation of 108 cell s ~· fragilis cell s and 106 cells of 
E. coli. Animals were i mplanted with a dou ble gelatin cap-
sule containing artificia l fecal material a s described in 
Materials and Methods and were necropsied a t 42 days. Abscess 
tissue was fixed in buffe red formalin, embed ded in paraffin, 
sectioned, and stained wi th Hand E. Lette r s: (L) lumen, 
(P) phagocytic cells, (GT) granulation tis sue, (A) adipose 
tissue. 
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present. However, microthrombi seen at this time could be ~xplained 
by the severe vasculitis observed and not necessarily to any specific 
response of !· fragilis. It is interesting that at 7 d, tissues 
infected with !· fragilis appeared to have an arterialization of the 
capillaries in the granulation tissue. However, the meaning of this 
finding is, as yet, obscure. 
It is clear from this brief examination of tissues that the 
response seen in animals infected with B. fragilis (or combinations 
with !· ,coli) is different from that seen in animals infected with 
E. coli alone. Extensive studies need to be performed to determine 
what is causing these pathogenic effects and to study them more 
critically in vitro. 
D. Factors affecting intraperitoneal abscess formation caused 
by B. fragilis. To study the actual role of each bacterial component 
pathogenesis, the effect of inoculum size of B. fragilis and/or E. 
coli, on abscess formation were determined. 
1. Effect of inoculum size on abscess formation. When the 
size of B. fragilis inoculum was varied from 107 to 1010 cells,all 
abscesses formed were small and not significantly different in weight 
from the encapsulated mass seen in the control animals (Table 5). 
Variation in the inoculum size of E. coli from 106 cells to 108 cells 
did not result in any difference in abscess size (Table 6). In fact, 
abscesses caused by an inoculum of 107 or 108 cells of !· coli were 
slightly smaller than those caused by 106 cells of E. coli. An inocu-
lum of higher than 108 cells resulted in lethal peritonitis. 
When animals were implanted with both B. fragilis and E. coli 
Group Number of 
animals 
1 10 
2 4 
3 4 
4 10 
5 4 
TABLE 5. 
Average weight of abscesses experimentally 
produced in rats by ~· fragilis 
Number of !· fragilis impreg-
nated in artificial fecal material 
None 
1010 cells 
109 cells 
108 cells 
7 10 cells 
a Mean + standard error 
Weight of encap-
sulated materiala 
0.69 + 0.09 b 
0.85 + 0.26 
0.73 + 0.03 
0.73 + 0.13 
0.67 + 0.33 
b When no bacteria were impregnated, only sterile artificial fecal material 
was found within the encapsulation and no pus was formed. 
VI 
00 
,~, 
Group 
1 
2 
3 
4 
Number of 
animals 
10 
10 
8 
8 
TABLE 6. 
Average weight of abscesses experimentally 
produced in rats by E. coli 
Number of E. coli impregnated 
in artificial fecal material 
None 
8 10 cells 
7 10 cells 
6 10 cells 
a Mean + standard error. 
Weight of encap-
sulated materiala 
b 0.60 + 0.09 
2.18 + 0.41 
2~94 + 0.31 
4.04 + 0.56 
b When no bacteria wer.e impregnated, only sterile artificial fecal material was 
found within the encapsulation and no pus was formed. 
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(Table 7) even small numbers of bacteria were sufficient to cause the 
formation of large abscesses. Representative abscesses caused by 
B. fragilis, _§. coli or both in combination are seen in Fig. 10. 
2. Effect of suspending material on abscess formation. 
Intraperitoneal abscesses are most often associated with trauma or 
spillage of intestinal contents into the abdomen. As shown above, an 
artificial fecal material in conjunction with bacteria was necessary 
to cause infection. This closely mimics colonic spillage without 
introducing the complexities of actual fecal material. 
Another factor associated with ability of these organisms to 
initiate infection might be the presence of clots formed during trauma 
or abdominal surgery. Although the clots resorb internally after a 
short time interval, they might still serve as an initial focus of 
infection. 
Animals implanted with plasma clots that had been impregnated 
with bacteria did not cause the formation of intraperitoneal abscesses 
by day 7. Clots began to dissolve immediately on implantation and had 
disappeared by day 7. In contrast to this when blood clots were im-
pregnated with bacteria, small well defined abscesses formed and per-
sisted to necropsy on day 14 (Fig. 12). It appears that localization 
of bacteria was necessary initially. However, if blood is present and 
a focus of infection forms, suspending material might not be necessary, 
and pathogenicity 9f the organisms could be determined without the 
further complication of a prolonged foreign body response. 
It appears that for intra-abdominal abscesses to form, localiza-
tion of bacteria was initially necessary. However, after initiation 
• 
.· >·-··~ ... ,., ·~..---- ......... ., 
Group Number of 
animals 
1 10 
2 5 
3 4 
4 5 
5 4 
TABLE 7. 
Average weight of abscesses caused by 
low numbers of B. fragilis and E. coli 
Organisms impregnated in 
artificial fecal material 
No bacteria 
~· fragilis4 (104 cells) E. coli (10 cells) 
~ . 
B. fragil~(lo- cells) 
E. coli (10 cells) 
!!_. fragilis 2 (10 cells) 
E. coli 
.,... --
~· fragilis1 (101 cells) 
_§,. coli .ClO cells) 
a Mean + standard error. 
Weight of encap-
sulated material 
0.69 + 0.09 b 
3.26 + 0.41 
3.28 + 0.49 
3.20 + 0.21 
2.48 + 0.49 
b When no bacteria were impregnated, only sterile artificial fecal material 
was found within the encapsulation and no pus was formed. 
a 
"' 1-' 
.·· 
~ 
Fig. 12. Intra-abdominal abscess in rats caused by implanta-
tion of blood clots impregna ted with 108 cells of 
~· fragilis . The arrow indicates a representative 
abscess formed in rats as specified above. 
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of the infection, solid material was no longer necessary. It should 
also be noted that the presence of blood was necessary, possibly due 
to its content of nutrients, vitamins, and/or ·iron. 
III. Effect of E. coli on the growth of B. fragilis in vitro. 
Although data from other investigators (Onderdonk et al., 1976) 
suggest that a synergistic interaction between aerobic and facultative 
organisms is involved in abscess formation, it is still not clear from 
our data (Table 4, Fig. 10) whether B. fragilis and E. coli actually 
interact to enhance the formation of intra-abdominal abscesses in rats. 
In order to investigate the nature of interactions between these two 
organisms more critically, their growth in_a mixed culture was examin-
ed in vitro. 
A. Growth of B. fragilis and E. coli in peptone media. 
1. Enhancement of !· fragilis growth in the presence of 
., 
E. coli. B. fragilis rapidly lost viability when incubated alone in 
== 
stored Bacto-peptone broth (lot #540620) at 37°C. In the same medium, 
however, !· coli grew optimally with a short lag period and a doubling 
time of approximately 20 min (Fig. 13). When B. fragilis was inoculat-
ed in the same medium together with !· coli, the B. fragilis showed an 
initial decline in viability as it did in pure culture. However, after 
4 
9 h to 12 h of incubation, growth of B. fragilis was initiated and 
eventually reached near maximal levels of growth in 24 h. This pheno-
menon was repeatedly observed whether the mixed cultures were incubat-
ed under aerobic or anaerobic conditions. In one particular lot of 
Bacto-peptone broth (Difco, peptone, lot #630023) the viability of 
Fig. 13. Enhancement of B. fragilis growth by!· coli and change 
in dissolved oxygen level during incubation. Cells were 
grown in Bacto-peptone (lot #540620) under aerobic con-
ditions at 37°C for 24 h. Dissolved oxygen ( o-o) was 
measured using an oxygen monitor equipped with a Clark 
oxygen electrode. Each point represents the mean of at 
least two samples. Symbols: •-•, viable!· coli when 
grown alone or in combination with B. fragilis; IJ.-IJ. 
- ' 
viable _!!. fragilis alone; e-e, viable !· fragilis when grown 
with E. coli in a mixed culture. 
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~· fragilis in a mixed culture dropped so rapidly that essentially no 
viable ~· fragilis cells could be recovered from the culture by 3 h 
(Fig. 14). However,~· fragilis growth initiated at 12 hand progress-
ed normally, reaching the maximal level by 24 h. These observations 
clearly indicate that under this condition, the initial growth of E. 
coli is required for the subsequent growth of ~· fragilis. 
2. Suitability of various peptone media for studying the 
in vitro interaction between B. fragilis and E. ~· Because it was 
experienced in the early phase of this in vitro study that reproduci-
ble results could be obtained only when the same batch of peptone was 
used, various peptone media were examined to see whether only certain 
types of peptone were suitable for the present study. 
Various lots of Bacto-peptone and other commercially available 
peptone media were tested under the same experimental conditions as 
employed for testing the lot /1540620. The results of the test are 
summarized in Tables 8 and 9. As evident in the tables, good to fair 
growth of !· fragilis occurred in the absence of E. coli in most of the 
peptone media tested. Although data are not shown, all peptone media 
supported good growth of !· coli. Since it was desirable for our pur-
pose to use a medium in which B. fragilis could grow only in the pre-
sence of E. coli, it was decided to use Bacto-peptone lot #540620 
throughout the subsequent study. 
3. Enhancement of B. fragilis growth by E. coli while 
separated by a dialysis membrane. To determine if physical contact 
between the two organisms is necessary for !· fragilis growth to occur, 
the organisms suspended in peptone broth were separated by a dialysis 
·d 
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Fig. 14. Enhancement of B. fragilis growth by !· ~ in Bacto-
peptone (lot #630023). Cultures were grown under aerobic 
conditions at 37°C for 24 h. Each point represents the 
mean of at least two samples. Viable cell numbers of less 
than 10 cells/ml could not be detected. In some cases, 
cell number dropped below this limit and were again count-
able at a later time. Symbols: •-•, ! coli alone or in 
combination with!· fragilis; j-£, !· fragilis alone; 
e-e, !· fragilis growing with !· coli. 
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TABLE 8. 
Growth of B. fragilis and oxygen levelsa in 
various peptone media (5%) 
b Medium 
Bacto-peptone 
Tryptone 
Thiotone 
Time 
storedc (h) 
0 
24 
48 
0 
24 
48 
0 
24 
48 
Growthd 
(Klett units at 540) 
24 h 48 h 
48 60 
0 0 
0 0 
46 97 
32 96 
15 90 
75 109 
75 110 
21 105 
Dissolved 
e 
oxygen 
(Jlmo1es/1) 
30 
67.5 
192.5 
45 
100 
ND 
40 
120 
ND 
a Growth and oxygen levels are representative of at least 2 
determinations. 
b Supplemented with 0.05% hemin. 
c Stored at room temperature for 24 h under aerobic conditions. 
d 5 The medium was inoculated with 2.5 x 10 B. fragilis cell/ml, 
and incubated under anaerobic conditions at 37°C. 
67 
e Measured by a Clark type electrode immediately before inocula-
tion. 
TABLE 9. 
Growth of B. frasilis in various 
lots of Bacto-peptone mediuma (5%) 
Lot number 
540620 
561172 
564852 
604607 
630023 
Growth5 
(viable cells/ml) 
10 
7,8 X 104 
1.7x 102 
1.19 X 109 
1.41 X 109 
a Stored at room temperature for 24 h 
under aerobic conditions and supple-
mented with 0.05% hemin. 
b The media was inoculated with 2.5 x 
105 !· fragilis cells/ml and incubated 
under anaerobic conditions at 37°C 
for 48 h. Growth is representative of 
at least 2 determinations. 
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membrane and then incubated aerobically at 37°C (data not shown). 
After 24 h of incubation, ~· coli grew from an original inoculum of 
approximately 105 cells/ml to an optimal level of 109 cells/ml, 
whereas no growth of ~· fragilis occurred. In fact, viable number of 
~· fragilis dropped from 105 to 103 cells/ml within that period. 
However, by 48 h, ~· fragilis grew to a level of 2 x 107 cells/ml. 
A similar result was obtained when the same culture system was incu-
bated anaerobically. These results indicate that direct cell to cell 
contact is not necessary for enhancement of B. fragilis growth by 
E. coli and that a possible factor(s) involved is dialyzable. 
4. Effect of selective inhibition of E. coli growth on the 
survival and growth of B. fragilis in mixed culture. Kanamycin is 
inhibitory to the growth of ~· coli but not B. fragilis. To determine 
the extent of ~· coli growth necessary for survival and subsequent 
growth of coexistent!· fragilis, kanamycin (100 ~g/ml, final concen-
tration) was added to separate sets of mixed cultures at various times 
of incubation. The results of these experiments are illustrated in 
Fig. 15. 
When kanamycin was added to the mixed culture at 0 time, ~· coli 
rapidly lost viability and dropped to a level of 20 cells/ml at 4 h 
and no growth of B. fragilis was observed (Fig. 15A). When the anti-
biotic was added at 2 h to the mixed culture in which E. coli had 
5 6 grown from 10 cells/ml to 2 x 10 cells/ml, most of the E. coli were 
rapidly killed. However, B. fragi1is began growing at 10 h, reaching 
2 x 106 cel1s/ml at 24 h. In case kanamycin was added at 4 h (Fig. 
15C), when E. coli had grown to 108 cells/ml, initiation of!· fragilis 
.~~ ; 
"' 
•· 
" 
Fig. 15. Effect of!· coli on the growth of!· fragilis in 
Bacto-peptone medium. Cultures were grown under aerobic 
conditions at 37°C for 24 h. Kanamycin (100 ~g/ml) was 
added at 0 time (A), 2 h (B) or 4 h (C) to selectively 
inhibit !· coli growth. Viable counts were determined 
as described in Materials and Methods. Each point re-
presents the mean of at least two samples. Symbols: 
•-•, ! . coli viable counts e .... , ! . fragil is viable 
counts. 
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growth occurred slighly earlier, reaching approximately 108 cells/ml 
by 24 h (Fig. 15). 
5. Effect of inoculum size of E. coli on growth of B. fra-
gilis in mixed culture. In order to determine the effect of the 
initial inoculum size of E. coli on B. fragilis growth in the mixed 
3 
culture system, two different inoculum sizes, 2 x 10 cells/ml, and 
1 10 cells/ml, were tested. As shown in Fig. 16, ~- fragilis growth_ 
in the mixed culture was not significantly altered when the inoculum 
size was reduced from 105 (Fig. 16) to 2 x 103 or 101 cells/mi. How-
l 
ever, when initial levels of !· coli were reduced to 10 cells/ml, 
viable numbers of B. fragilis obtained at 24 h were significantly 
3 5 lower than that observed with the 10 or 10 cell inoculum of E. ££!!· 
It is apparent from these observations that, under certain 
conditions, growth of ~- fragilis is markedly enhanced by the initial 
coexistence of E. coli. 
6. Mechanism of the enhancement of B. fragilis growth by 
E. coli in Bacto-peptone medium. A variety of mechanisms might be 
responsible for the enhancement of ~· fragilis growth by !· coli in a 
mixed culture. These include the following: a) Dissolved oxygen level 
in media used was too high to allow ~· fragilis growth. The utiliza-
tion of oxygen by !· coli during its growth reduced oxygen to a very 
low level, allowing growth of ~· fragilis; b) Preformed toxic sub-
stances might be present, or exposure of media to storage might cause 
the production of toxic peroxides or superoxides. E. coli could uti-
lize or alter toxic substances on its growth, and is capable of ridding 
the media of toxic oxygen products by its catalase and superoxide dis-
,-) 
11~ 
Fig. 16. Effect of~· coli inoculum size on the enhancement of 
!· fragilis growth in Bacto-peptone medium. 2 x 103 
1 
cells (A) or 10 cells (B) of ~· coli were inoculated 
with 105 cells of B. fragilis to Bacto-peptone medium and 
incubated under aerobic conditions at 37°C for 24 h. Viable 
cell number was determined as described in Materials and 
Methods. Each point represents the mean of at least two 
samples. Symbols: x-x, growth of!· fragilis alone, o-o, 
growth of !· fragilis when in combination with an inoculum 
1 
of 10 cells of ~· coli/ml; Growth of ~· coli after inocula-
tion of 5 x 103 cells/ml ( •- • ), or 101 cells/ml (!-t) 
with B. fragilis was also. 
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mutase enzymes. ~· fragilis could then initiate growth; c) ~· coli 
might produce and excrete vitamins or nutrients stimulatory to E. coli. 
This (these) substance(s) might be some type of material already 
defined as a growth factor for~· fragilis, or may be an as yet un-
identified stimulatory material(s). 
To determine which of these mechanisms were actually involved in 
E. coli induced enhancement of !· fragilis growth in mixed culture, 
each of the possibilities was analyzed individually. 
a. Dissolved oxygen. The dissolved oxygen level of variously 
treated Bacto-peptone media and growth of B. fragilis in each are 
shown in Table 10. The level of dissolved oxygen in media immediately 
. -6 
after autoclaving was approximately 30 x 10 moles/1. B. fragilis 
grew in this medium or in freshly autoclaved media that had been 
placed immediately under anaerobic conditions and stored there before 
use. However, if media were stored aerobically, the dissolved oxygen 
level increased to 67 x 10-6 moles/1 by 24 h and increased further to 
190 x 10-6 moles/1 after 48 h. ~· fragilis never grew either aerobic-
ally or anaerobically in peptone stored for 24 h or longer after 
autoclaving. 
The growth of ~· coli in stored peptone medium reduced dissolved 
oxygen to a level below that observed in freshly autoclaved medium. 
After oxygen level was lowered by~· coli, initiation of B. fragilis 
growth occurred. It has been demonstrated (data not shown) that in 
a mixed culture shaking under aerobic conditions, ~· fragilis will not 
grow. In the same respect, vortexing freshly autoclaved peptone 
diminished the amount of~. fragilis growth (Table 10). The reduction 
TABLE 10. 
Growth of B. fragilis and oxygen levelsa in Bacto-peptone 
medium (5%) stored under various conditions 
Conditio~ of 
storage 
None (Freshly 
autoclaved) 
Vortexed (2 min) 
24 h under anaerobic 
conditions (24°C) 
24 h under aerobic 
conditions 
48 h under aerobic 
conditions 
24 h aerobically, then 
24 h anaerobically 
24 h aerobically, then 
boiled 30 min. 
c Growth (cells/ml) 
5.5 X 108 
8.0 X 106 
4.9 X 109 
2.4 X 103 
10 
8.3 X 102 
3.6 X 10 6 
d Dissolved oxygen 
at time of inoculation 
(].lmoles/1) 
30 
187.5 
10.2 
67.5 
192.5 
10 
47.5 
a Growth and oxygen levels are representative of at least 2 deter-
minations. 
b Supplemented with 0.05% hemin and kept at 25°C during storage. 
c 
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Media were inoculated immediately after the designated treatment 
to a final concentration of 2.5 x 105 cells/ml of B. fragilis and 
and incubated at 37°C for 24 h anaerobically. 
d Measured by a Clark type electrode immediately before inoculation. 
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of dissolved oxygen, then, is vital to the growth of B. fragilis. How-
ever, this may not be the only action of !· coli that enhances B. fra-
gilis growth. 
If oxygen alone were responsible for inability of B. fragilis to 
grow, stored peptone media, which was treated by procedures to lower 
oxygen level without altering other parameters, ought to subsequently 
allow growth of !· fragilis. Media which was initially stored for 24 
h under aerobic conditions, was subsequently placed under anaerobic 
conditions for 24 h or boiled for 30 min before inoculation with B. 
fragilis. B. fragilis grew only slightly in stored media that was 
boiled before inoculation, and actually lost viability in stored pep-
tone placed under anaerobic conditions for 24 h before inoculation 
(Table 10). This would indicate that reduction of oxygen cannot com-
pletely account for enhancement of B. fragilis growth. In confirma-
tion of these findings, other facultative microorganisms, ~· vulgaris, 
K. pneumonia and !· aureus, all known to rapidly reduce oxygen tension 
in media, were grown in mixed culture with!· fragilis (Table 11). 
S. aureus did not stimulate growth of the anaerobe. Although ~· vul-
garis and K. pneumoniae did enhance !· fragilis growth, enhancement 
was not observed until 48 h, whereas enhancement by !· coli was observ-
ed at 24 h. 
E. coli is apparently responsible for reducing oxygen level in 
media, a requirement for growth of the!· fragilis. However, this 
mechanism is not alone sufficient to account for the optimal !· fra-
gilis growth seen in mixed culture. Other mechanisms must also be 
participating in this phenomenon. 
TABLE 11. 
Enhancement of ~· fragilis growth by 
other organisms in 5% Bacto-peptonea 
Growth of B. 
Organismb 
fragilis 
viable cell/ml at 
24 h 48 h 
E. coli 1.72 X 107 6.0 X 108 
P. vulgaris 7.1 X 104 4.9 X 108 
K. 2neumoniae 103 1.9x 109 
s. aureus NDC 3 X 104 
a Supplemented with 0.05% hemin 
b Media were inoculated with 255 x 10
5 
B. fragilis cells/ml, 3 x 10 cells/ml 
of ~· xulgaris or K. 2neumoniae, or 
3 x 10 cells/ml of S. aureus, and 
incubated aerobically at 37° C. Growth 
is representative of at least 2 deter-
minations. 
c ND = not done. 
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b. Removal of toxic superoxide radicals or other growth inhi-
bitors. To determine if removal of superoxide radicals would allow 
growth of B. fragilis in peptone broth, superoxide dismutase (65 
units activity/ml), prepared as described in Materials and Methods, 
was added to stored peptone (Table 12). When superoxide dismutase was 
not added, all B. fragilis lost viability by 24 h. Addition of super-
oxide dismutase to the medium slowed the rate of viability loss, 
although by 48 h complete loss in viability of B. fragilis was still 
observed. 
It is possible that !· coli is utilizing or removing toxic 
substances in the stored peptone that are inhibitory to the growth of 
!· fragilis. To test this possibility, the stored peptone was treated 
with activated charcoal, filter sterilized and then inoculated with 
!· fragilis. The result of this study is shown in Table 13. B. fra-
gilis grew in such a peptone medium to a level of 109 cells/ml indi-
eating that there are some toxic substances in stored peptone that can 
be removed or altered by!· coli when in mixed culture. 
c. E. coli production of nutrients or vitamins that stimulate 
the growth of B. fragilis. To determine if preformed structures or 
internal components of !· coli would stimulate growth of B. fragilis, 
heat killed !· coli were inoculated 
peptone under anaerobic conditions. 
along with!· fragilis to stored 
8 As many as 10 cells of E. coli 
were heat killed by boiling for 30 minutes. Addition of the heat 
killed E. coli to stored peptone did not stimulate the growth of !· 
fragilis under any experimental condition tested (data not showq). 
Stored peptone was supplemented with hemin, menadione, ~onium 
TABLE 12 
Effect of superoxide dismutase on the growth 
of B. fragilis in 5% Bacto-peptone mediuma 
Medium 
Stared peptone c 
Stored peptone+ 
65 units/ml SOD 
Control (freshly 
autoclaved peptone) 
Growth 
viable cells/ml at 
24 h 48 h 
10 10 
3.0 X 102 10 
1.6x 109 1.7x 
aSupplemented with 0.5% hemin. 
9 
10 
bMedia were inoculated with 2.5 x 105 ~· fragilis 
cells/ml and incubated anaerobically at 37° c. 
Growth is representative of at least two de-
terminations. 
cStored aerobically for 24 h at 25° c. 
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TABLE 13. 
Growth of !· fragilis in Bacto-peptone mediuma (5%) 
treated with activated charcoal 
Treatment 
None 
Stored medium adsorb-
ed with activated 
charcoal 
Control 
(freshly autoclaved) 
Growth 
viable cells/ml 
10 
3.28 X 109 
9 1.45 X 10 
a Supplemented with 0.05% hemin. 
b Media were inoculated with !· fragilis 
to a final concentration of 2.5 x 105 
cells/ml and incubated anaerobically at 
37° C for 24 h. Growth is representative 
of at least 2 determinations. 
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sulfate, ferrous sulfate, and/or a vitamin mixture (Table 14). All of 
these substances are known to be stimulatory to ~· fragilis under other 
circumstances (Varel and Bryant, 1974). In no case did these materials 
enhance the growth of~· fragilis. 
An experiment was devised to determine if !· coli produced sub-
stances that were stimulatory to~· fragilis. Stored medium (5.0 ml) 
was supplemented with 0-5.0 ml !· coli spent medium, and the volumes 
equilibrated to 10 ml with sterile saline. Tubes were then inoculated 
with ~· fragilis to 105 cells/ml. Addition of 2 ml or more of spent 
medium allow optimal growth of ~· fragilis to 109 cells/ml by 24 h 
(Table 15). This suggests that the spent medium contained material(s) 
produced by!· coli capable of stimulating growth of~· fragilis. A 
dilution of toxins was not responsible for ~· fragilis growth since 
stored medium to which various amounts of sterile saline had been 
added did not support growth of~· fragilis. 
From the data presented above, it is likely that at least three 
different mechanisms are jointly responsible for growth of ~· fragilis 
in mixed culture in stored peptone. These are: 1) removal of dissolv-
ed oxygen, 2) removal or inactivation of toxic substances and 3) pro-
duction of a factor(s) stimulatory to the growth of~· fragilis. 
B. Interaction of B. fragilis and E. coli when grown in mixed 
culture in semi-synthetic medium. The data presented in the preceed-
ing section strongly indicate that the stimulation of B. fragilis 
growth by!· coli in mixed cultures is mediated, at least in part, by 
a substance or substances accumulating in the medium as a result of 
!· coli growth. To further characterize such substances it was thought 
( \ 
) 
" 
i 
TABLE 14 
Growth of B. fragilis in Bacto-peptone ~edium 
(Lot #540620) supplemented with various additives 
Growth 
Supplements viable cells/ml 
Hemin (0.05%) 10 
Hemin + Menadione (O.OOO~o) 10 
Hemin + Cyanocobalamin (ng/ml) 10 
5 10 
25 10 
so 10 
100 10 
500 10 
Hemin + Ammonium sulfate (mM) 
0.03 
0.15 
0.30 
0.60 
3.00 
Hemin+ Menadione (0.0005%) 
+ Cyanocobalamin (SOng) 
+ Ammonium sulfate (0.3 mM) 
+ Vitamin mix 
10 
10 
10 
10 
10 
3.5 X 102 
aThe media were inoculated with 2.5 x 105 ~· fragilis 
cells/ml and incubated at 37° C for 24 h anaero-
bically. Growth is representative of at least 
two determinations. / 
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TABLE 15. 
Growth of !· fragilis in stored Bacto-peptone medium 
supplemented with various amounts of spent medium 
Stored Spent diluent !· fragilis growthc 
peptone a peptoneb (H20) (viable cells/ml) 
10 0 0 3.0 X 103 
5 0 5 1.1 X 103 
5 1 4 5.7 X 108 
5 2 3 2.3 X 109 
5 3 2 2.5 X 109 
5 4 1 2.3 X 109 
5 5 0 2.6 X 109 
0 10 0 2.9 X 109 
' ' i 
/ 
a Stored atLroom temperature for 24 h under 
' aerobic co~~itions. 
b Spent by 24 h of E. coli growth and filter 
sterilized before use. 
c The media was inoculated with a 2.5 x 105 
B. fragilis cells/ml and incubated under 
anaerobic conditions for 48 h at 37° c. 
Growth is representative of at least 2 
determinations. 
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that a synthetic or semi-synthetic medium was more preferred to complex 
peptone media. On the basis of several preliminary experiments, a 
modification of the semi-synthetic medium of Roberts et al. (1955) was 
selected and used throughout this investigation. 
1. Kinetic studies of enhancement of B. fragilis growth by 
E. coli. B. fragilis slowly lost viability when incubated alone in the 
---
semi-synthetic medium, either aerobically or anaerobically (Fig. 17). 
No initial rapid drop in!· fragilis viability, as that seen in certain 
peptone media (iig. 13, 14), was observed in this medium. This obser-
vation indicates that toxic substances that were shown to be present 
in specific lots of peptone media are not present in the semi-synthe-
tic medium. Absence of toxic substances in this medium was further 
confirmed by demonstrating that semi-synthetic medium would not inhi-
bit !· fragilis growth using the agar diffusion method described below 
(Fig. 18). In contrast to the loss in viability of B. fragilis in 
pure culture, !· fragilis, in mixed culture with E. coli, increased in 
number from approximately 105 cells/ml to 107 cells/ml in 48 h. 
2. Enhancement of B. fragilis growth in mixed culture after 
inhibition of E. coli by kanamycin. To determine how much E. coli 
growth was necessary to initiate the growth of!· fragilis, !· coli 
was inhibited by the addition of kanamycin (final concentration, 100 
llg/ml) at various times' after inoculation of mixed cultures. When 
-, 
kanamycin was added at 0 tf~ or 2 h, growth of B. fragilis did not 
occur (Table 16). In fact, a slight loss in viability was noted. 
However, kanamycin added at 4 h did not prevent the subsequent en-
hancement of B. fragilis growth. 
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Fig. 17. Stimulation of B. fragilis growth by the growth of!· coli 
in semi-synthetic medium. Approximately 105 cells of !· fragilis 
!· ££!!, or the combination of both were inoculated to semi-
synthetic medium, and incubated at 37°C under aerobic conditions. 
Viable cell number was determined as described in Materials and 
Methods. Each point represents the mean of at least two samples. 
Symbols: •-•, ~· coli alone or mixed with!· fragilis; A-A, 
!· fragilis alone; e-e, !· fragilis mixed with!· coli. 
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Fig. 18. Lack of inhibition of B. frag ilis growth on enriched 
TSA by stored peptone or semi-synthe tic medium. The 
surface of enriched TSA was spre ad with approx imately 
106 cells of~· fragilis and wells cut. The wells 
were f illed with 0.25 ml of (A and B) stored peptone, 
(C and D) semi-synthetic medium, or (E) hemin (control). 
L 
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TABLE 16. 
Effect of E. coli growtha on the growth of 
B. fragilis in semi-synthetic medium 
Time of supplementation 
with kanamycinb (h) 
None added 
0 
2 
4 
B. fragilis growthc 
(cells/ml) 
1.6x 107 
5 1.0 X 10 
8.0 X 104 
1.7 X 107 
a Broth was inoculated with 2.5 x 105 cells 
each of !· fragilis and !· coli. 
b !· coli growth was selectively halted at the 
designated times by addition of kanamycin to 
a final concentration of 100 ug/ml. 
c Viable cell number of B. fragilis was deter-
mined after anaerobic incubation for 48 h 
at 37° C. 
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3. Demonstration of the B. fragilis growth stimulatory 
As described above, B. fragilis growth was stimulated by ~· coli in 
J broth media. To confirm this finding, and to establish a rapid 
method for qualitative determination of the presence of !· fragilis 
growth stimulatory materials, a plate agar diffusion technique was 
developed. Wells were cut in TSA plates, !· fragilis seeded onto the 
plate surfaces and the wells filled with !· coli spent media. After 
seeded plates containing stored peptone or semi-synthetic medium were 
incubated for 24 h at 37°C under anaerobic conditions, visual inspec-
tion of the plates revealed no stimulation of !· fragilis growth (Fig. 
19). However, it was clearly demonstrated, as seen in Fig. 19, that 
spent peptone and spent semi-synthetic medium did stimulate the 
growth of !· fragilis, confirming results observed in the broth 
method. This technique will be used to determine the ability of spent 
media treated in various manners to retain the stimulatory ability. 
C. Some properties of the B. fragilis growth stimulatory 
factor(s) produced by E. coli. In order to further define some of the 
properties of the stimulatory factors produced by !· coli, spent semi-
synthetic medium was treated in a variety of manners and then assayed 
for the capacity to stimulate !· fragilis growth in the plate assay 
system. Some general properties of the stimulatory materials can be 
seen in Table 17 a~d effect of spent medium on !· fragilis stimulation 
after various treatments observed in Fig. 20. The stimulatory materi-
al was found to be quite stable to heat, acid or alkali. Treatment by 
boiling for 30 min, or exposure to pH 2.0 or pH 12.0 for 30 min, did 
... 
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Fig. 19. Stimulation of ~· fragilis growth by !· ~ spent peptone 
and spent semi-synthetic medium. The surface of TSB was 
spread with approximately 106 cells of ~· fragilis and 
wells cut. The wells were filled with 0.25 ml of (A) hemin 
alone (control), (B) stored peptone medium, (C) spent pep-
tone medium, (D) spent semi-synthetic medium, or (E) 
semi-synthetic medium. 
TABLE 17 
Effect of various treatments on the B. fragilis 
stimulatory activity of spent semi-synthetic medium 
Treatment of 
spent peptone 
None 
Boiling ( 30 min) 
Dialysis (against 
distilled H2o) 
Acid (pH 2.0, 1 h) 
Alkali (pH12.0, 1 h) 
Cationic resin 
(cl- charged) 
Anionic resin 
(H+ charged) 
Ether extraction 
Stimulationa of 
B. fragilis growth 
+ 
+ 
+ 
+ 
+ 
aStimulation dete~ined on solid me~i~m. 
Approximately 10 cells of ~· frag~l~s 
were spread on the surface of either TSA 
or enriched TSA. Wells were cut, and 
treated spent medium placed in the wells. 
Growth stimulation was defined as enhanced 
growth around the wells 
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Fig. 20. Stimulation of~· fragilis growth by spent semi-synthetic 
medium subjected to various treatments. The surface of 
TSA was spread with approximately 106 cells of~· fragilis. 
Wells were cut and filled with 0.25 ml of test fluids. 
Wells A and F contain hemin (control), well E contains semi-
synthetic medium (concentrated 20-fold), and well G contains 
20-fold concentrated spent semi-synthetic medium. The other 
wells contain spent semi-synthetic medium concentrated 
and treated by (B) boiling for 30 min., (C) acid (pH 2.0), 
1 h (D) alkali (pH 12.0), 1 h, (H) dialyzed extensively 
against distilled water, (I) exposure to cationic (Cl ~ba 
resin, or (J) exposure to anionic (H+ charged) resin. 
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not destroy capacity to stimulate ~· fragilis growth. The molecular 
weight of the material appeared to be less than 10,000 since dialyzed 
spent medium no longer stimulated ~· fragilis. Ether did not extract 
the stimulatory materials, although it was removed by both cationic 
and anionic exchange resins. 
DISCUSSION 
This investigation has provided some new and significant 
information as to the role and the nature of microbial interactions 
in the pathogenesis of intraperitoneal abscess formation. First, it 
was shown that the combination of ~· fragilis and E. coli caused the 
formation of large intra-abdominal abscesses in rats, although abscess 
weight was not statistically different from that observed in infec-
tions induced by !· coli alone. Both ~· fragilis and E. coli were 
independently able to cause intraperitoneal abscess formation. 
Second, an interaction between !· coli and ~· fragilis was demon-
. 
strated for the first time in vitro; the growth of !· fragilis was 
greatly enhanced by !· coli growth in certain peptone media and a 
semi-synthetic medium. In addition, the present study has clarified 
two important questions pertaining to the susceptibility of~· fragilis 
and!· coli to oxygen and low temperature. 
I. Susceptibility of B. fragilis and E. coli to oxygen and low tem-
perature. 
B. fragilis is a mesophilic (optimal growth temperature: 37°C) 
and obligately anaerobic organism. Since it was often necessary to 
handle this organism in open air, ot-to store bacterial specimens for 
-, 
later processing, we initiallyrlnvestigated the effects of oxygen and 
other storage conditions on the survival of this organism. Although 
it has been relatively well established that clinically 
important anaerobic bacteria are tolerant to exposure to atmospheric 
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oxygen (Bartlett et al., 1976; Loesche, 1968; Tally et al., 1975) 
there is still controversy as to whether anaerobic bacteria can be 
safely exposed to low temperature (Finegold et al., 1974; Dowell and 
Hawkins, 1974; Holdeman and Moore, 1972). We believe that preliminary 
experiments investigating the effects of these parameters are essen-
tial for drawing valid conclusions from our e~eriments. 
Unlike some of the strict anaerobes, !· fragilis was found to 
be quite oxygen tolerant, although no growth took place under aerobic 
conditions (Fig. 2, 4, 5, 6). This high degree of resistance to 
oxygen in our strain of !· fragilis does not seem to be unique to this 
particular isolate. The data published from several other labora-
tories also indicate that !· fragilis is in general quite tolerant to 
oxygen (Bartlett eta!., 1976; Loesche, 1969; Tally et al., 1975). 
The biochemical basis of this unique oxygen tolerance of the anaerobe, 
!· fragilis, has been recently elucidated. Tally et al. (1977) and 
others (Gregory et al., 1978) have demonstrated that low levels of 
superoxide dismutase, the enzyme that converts toxic superoxide 
radicals to a nontoxic form, can be found in B. fragilis. More 
detailed biochemical reactions involved in this detoxifying mechanism 
are found in reviews by Fridovich (1975) and Halliwell (1978). Most 
strict anaerobes do not contain this enzyme and are rapidly rendered 
nonviable by the action of superoxi~ radicals generated in the 
~· ~ 
aerobic environmen~. 
It is generally accepted practice in microbiology that cultures 
stored for later processing are kept at low temperatures, most 
commonly at 4°C. However, whether one may store cultures containing 
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strict anaerobes in a similar manner has been disputed for some time 
among clinical microbiologists. Some (Dowell and Hawkins, 1974; 
Holdeman and twore, 1972) warned that specimens should not be exposed 
to chilling since anaerobes are highly susceptible to low temperatures. 
On the other hand, Finegold et al. (1974) recommended that these 
specimens should be refrigerated to slow down the growth of coexis-
tent facultative bacteria if the specimens could not be cultured 
within 2 h. 
Our data (Fig. 2-8) show that !· fragilis was rapidly killed at 
low temperature, both in vitro and in experimentally produced pus, 
under most experimental conditions tested. Other investigators 
(Gorrill and McNeil, 1960; Hegarty and Weeks, 1940; St~ange and Dark, 
1962) have also demonstrated the lethal effect of low temperature on 
gram negative organisms. Strange and Dark (1962) demonstrated that 
chilling was lethal to Enterobacter aerogenes to varying degrees, 
depending on the phase of growth, the diluent, and the concentration 
of bacteria. In 1972, Leder demonstrated that glycerol would protect 
against lethality from cold shock by increasing osmotic pressure. In 
agreement with this finding, we have shown that increasing osmotic 
pressure by the addition of CaC12 and sucrose (Table 2) could greatly 
reduce the lethality normally observed after exposure to low tempera-
ture. A leakage of endogenous constituents (Strange and Dark, 1962) 
due to a precipitation (Ring, 1972) or crystallization (Leder, 1972) 
of certain membrane lipids was thought to be responsible for the 
lethality to microorganisms. Whether a simi!~ mechanism may be 
"\__; 1 
responsible for the killing of B. fragilis remains to be determined. 
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On the basis of the data obtained in our preliminary experiments, (a) 
all cultures were" processed immediately after collection, or freshly 
grown cultures were routinely used so that no prolonged storage perllrls 
were required, and (b) experiments involving~· fragilis were per-
formed on the bench under aerobic conditions except that all anaerobes 
were incubated under anaerobic conditions. 
II. In vivo and in vitro interaction of B. fragilis and E. coli. 
Because the animal model devised in this study not only enabled 
us to accurately control the type and number of bacteria to be 
implanted into the peritoneal cavity, but also allowed the implanted 
organisms to remain at the site of inoculation, we were able to evalu-
ate the abscess forming ability of !· fragilis and!· coli more pre-
cisely. In addition, the foreign material in which the microorganisms 
were impregnated roughly simulated fecal material, both in consistency 
and in the fact that it contained a ground meat mixed with cellulose. 
Since our model employed a defined artificial fecal material free from 
unidentified enteric bacteria and their products, we believe that it 
was better suited for this type of study than any other models pre-
viously reported. 
Several investigators (Meleney, 1932; Rite et al., 1949; Lorber 
and Swenson, 1975; Stone et al., 1975; DeHaan et al., 1974; Finegold 
and Rosenblatt, 1973) have suggested that a "synergistic" mechanism 
between aerobic and anaerobic microorganisms might be involved in the 
development of anaerobic infections. However, in most instances, 
evidence presented in support of their conclusion is far from con-
~J 
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vincing. Furthermore, the term "microbial synergy" has been used 
indiscriminantly, and often incorrectly. Synergism, in the strict 
sense, refers to a bilateral relationship in which both populations 
benefit from each other (Frederickson, 1977). In most cases, (Lorber 
and Swenson, 1975; Stone et al., 1975; DeHaan et al., 1974; Finegold 
and Rosenblatt, 1973), the involvement of microbial synergy in the 
formation of anaerobic abscess was suggested only on the basis of the 
fact that high percentages of specimens collected from anaerobic 
infections contain a mixed flora of aerob~c and anaerobic bacteria. 
Considering the complex nature of microbial flora contaminating wounds 
or the abdominal cavity, it is not too surprising to find a variety of 
microorganisms, both aerobic and anaerobic, in the infected lesions. 
There has been no convincing evidence presented in prior studies 
indicating that both aerobic and anaerobic bacteria synergistically 
participate in the development of such infections. 
There have been, however, a few investigations that have pro-
vided some experimental evidence to support this theory of synergism. 
Altemeier (1942) performed some rather preliminary studies on the 
pathogenicity of mixed cultures in guinea pigs. He reported that a 
mixed flora of facultative aerobes and anaerobic bacteria was isolated 
from 96/100 patients with perforated appendix. Subcutaneous implan-
tation of pure cultures of the organisms into guinea pigs failed to 
produce gangrenous lesions. However, when certain combinations of 
these organisms were implanted, animals developed extensive cellulitis 
accompanied by gangrene. Somewhat similar findings were reported by 
) 
other investigators (Meleney, 1932; Hite et:jal., 1949). More recently, 
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an apparently true synergism between !· coli and !· fragilis in the 
formation of intraperitoneal abscess in rats was reported by Onderdonk 
et al. (1975). In their study, no animals implanted with E. coli, 
enterococcus, !· fragilis or F. varium alone developed intra-abdominal 
abscesses. Likewise, the combination of either anaerobes alone (!. 
fragilis and!· varium), or aerobes alone (!. coli and enterococcus), 
did not cause abscesses. However, 89-100% of animals receiving com-
binations of one aerobe and one anaerobe developed abscesses by 7 days. 
7 The specific combination of E. coli (1~3 x 10 cells/ml) and B. fra-
gilis (2.5 x 107 cells/ml) produced intra-abdominal abscesses in 100% 
of the animals. 
Our results (Tables 4, 5, Fig. 10) agree with the~conclusion of 
Onderdonk et al. (1975) in that the combination of !· fragilis and 
!· coli resulted in the formation of large intra-abdominal abscesses. 
However, in contrast to their findings, we have found both !· coli and 
!· fragilis to be independently capable of causing intraperitoneal 
abscesses to form in rats (Table 4, 5, Fig. 10). Our results are 
consistent with the observations of others that B. fragilis alone can 
cause intra-abdominal abscesses in experimental animals (Hill et al., 
1974; McConville et al., 1976; Renz et al., 1975; Walker and Wilkins, 
1976). In our animal model, it was possible to produce intra-abdominal 
abscesses with E. coli alone (Table 4, 6, Fig. 10). T~ our knowledge 
~r 
this is the first study demonstrating intraperitoneal abscess forma-
tion by a gram negative facultative rod. Our finding is difficult to 
reconcile with the data reported by Onderdonk et al. (1975), who 
showed that presenc~f both E. coli and B. fragilis was necessary for 
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the abscess formation. However, Onderdonk et al. (1975) and others 
(Nichols et al., 1978), have used sterile cecal contents (which con-
tain a multitude of bacterial endproducts, lysed bacteria, and bac-
terial components), as well as barium sulfate, to help initiate and 
potentiate abscess formation. The problems associated with this use 
of a complex inoculum and unnatural additives was avoided by our use 
of an artificial fecal material. In addition, Onderdonk et al. (1975) 
used rat strains of B. fragilis and !· coli, whereas organisms used 
in this investigation were human isolates from actual intraperitoneal 
abscesses. The strain of rats used in each study also differed. 
The elucidation of types of microorganisms actually involved in 
pathogenesis is a very significant consideration when determining 
appropriate antibiotic therapy for these infections. Currently, there 
are two major approaches for the treatment of anaerobic abscesses. 
First, if truly synergistic interaction is involved in abscess forma-
tion as shown by Onderdonk et al. (1975), treatment of either compo-
nent alone should prevent abscess formation. In fact, some investi-
gators (Polk, 1977; Stone et al., 1975) suggested that if only the 
aerobic component were treated, anaerobic infections could be pre-
vented. Polk (1977) observed that failure to treat mixed aerobic-
anaerobic infections with cephaloridine resulted in a fourfold rise 
in infection rate. Stone et 
effectiveness of clindamycin 
al. (1975)Jperformed a study on the 
\_/-
or cephaloridine on patients with infec-
tions resulting from abdominal disease, surgery or trauma. Use of 
cephalothin, which is relatively ineffective against ~· fragilis 
resulted in an infection rate of 3%. These data suggest that treat-
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ment of the aerobic component of the mixed flora will be sufficient to 
reduce rate of infection. In contrast o this, several investigators 
(Busch et al., 1976; Griffith et al., 1977; Klastersky and Husson, 
1977; Weinstein et al., 1974) have emphasized the need for treatment 
of both aerobic and anaerobic flora or a mixed infection. Using a 
model of abdominal sepsis developed earlier, Weinstein et al. (1974) 
studied the efficacy of gentamicin alone, clindamycin alone, or the 
combination of both antibiotics in the treatment of anaerobic infec-
tions. He demonstrated that gentamicin, effective against the aerobic 
flora, greatly reduced peritonitis, but not the rate of abscess forma-
tion, whereas clindamycin, affecting !· fragilis, greatly reduced the 
rate of abscess formation, but not peritonitis. Both antibiotics 
were necessary for optimal therapy of a mixed infection. Fass et al. 
(1978) demonstrated the efficacy and safety of this combination in 
treatment of clinical anaerobic infections. Other investigators 
(Busch et al., 1976; Griffith et al., 1977; Klastersky and Husson, 
1977) studied various combinations of therapy for the treatment of 
anaerobic infections and sugge)ted that both aerobic and anaerobic 
ganisms should be treated since too little is known about the 
-) 
thogenesis of such mixed infections to do otherwise~~- .The results 
;Jf our animal studies demonstrate experimentally that both aerobic and 
~anaerobic flora should be treated in a mixed infection. Since both 
I 
B. fragilis and ~· coli were individually able to cause intraperitoneal 
abscesses, it would be necessary to treat both organisms to completely 
prevent abscesses from forming. 
Bowel spillage, resulting from disease, trauma, or abdominal 
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surgery, often results in intra-abdominal abscess formation. However, 
depending on the conditions of spillage, infection may not occur, a 
peritonitis may develop, only an abscess might form, or a peritonitis 
followed by abscess might be seen. Until now, there has been little 
experimental data to explain the factors which determine the outcome 
of spillage of intestinal contents. Using our animal model, the effect 
of various factors on such infections was examined in an attempt to 
more clearly understand the actual role of B. fragilis and E. coli in 
pathogenesis of intra-abdominal sepsis. 
It is possible that no infection will result from spillage of 
colonic contents into the peritoneal cavity. If the material is quite 
fluid, =:~~ of organisms small, the contaminating material will 
rapidly ~iffuse throughout the peritoneal cavity and be effectively 
phagocytized by the body's defense mechanisms. We have shown that if 
microorganisms are not held within a localized area by the some type 
of solid material or semi-solid material, abscess formation does not 
occur (Fig. 9). In no c~e did direct inoculation of!· fragilis 
alone, or the combination of B. fragilis and !· coli, into the peri-
toneal cavity result in intraperitoneal abscesses in rats. E. coli 
was rapidly phagocytized and could not be isolated from the abdominal 
cavity by 3 days, whereas !· fragilis could still be isolated on day 
15 from the abdomen (data not shown). Although!· fragilis has been 
shown to be readily engulfed and killed by rabbit polymorphonuclear 
leukocytes in vitro (Casciato et al., 1975; Bjornson and Hill, 1973), 
the chemotactic activity of !· fragilis endotoxin for phagocytic cells 
appeared to be greatly reduced when compared to classical gram nega-
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tive endotoxins (Sveen, 1977). !· fragilis lipopolysaccharide did 
generate a leukocyte chemotactic factor (Sveen, 1978) even though 
phagocytic cells did not appear to be effectively mobilized in the 
B. fragilis infection. 
Recently, a polysaccharide capsule has been discovered surround-
ing !· fragilis subsp. fragilis (Kasper and Seiler, 1975) and has been 
implicated in the pathogenesis of this organism. Kasper et al. (1977) 
demonstrated that all strains of subsp. fragilis possessed this poly-
saccharide, whereas other subspecies of B. fragilis did not have the 
capsule. Rowley (1971) has suggested that the thickness of a bacterial 
capsule is a major factor in determining virulence. Onderdonk et al. 
(1977) showed that encapsulated strains of !· fragilis usually caused 
I 
intraperito eal abscess in rats whereas unencapsulated strains usually 
did not i duce abscess. In their model, capsular material alone 
actually i du ed abscess formation. It was also shown (Onderdonk et 
al., 1978) that encapsulated strains of!· fragilis adhered to rat 
peritoneal ep~thelium better than unencapsulated strains, suggesting a 
role in virulence 6f the organism. Contrary to this finding that only 
subspecies fragilis possesses a capsule, Babb and Cummins (1978) has 
shown that three of the other four subspecies, vulgatus, thetaiotao-
micron and ovatus, also possess capsular material. Consequently, the 
role of this capsule in the pathogenesis of B. fragilis still remains 
unclear. 
If the number of certain bacteria, especially !· coli, spilled 
during trauma is high, the risk of severe peritonitis exists. The 
problem arises from the fact that E. coli contains a classical endo-
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toxin and is normally found in levels of 108 to 1010 bacteria per g 
of colonic contents (Attebery et al., 1971). In fact, only~- fra-
gilis outnumbers !· coli as normal flora of the human colon. Peri-
tonitis is usually induced by the classical endotoxin of facultative 
gram negative bacteria. It is known to elicit fever, the Shwartzman 
reaction, disseminated intravascular coagulation (DIC), and vascular 
collapse in humans. This does not appear to be the case for ~· fra-
gilis. This may be because the lipopolysaccharide structure of B. 
fragilis is atypical when compared to that of facultative forms in 
that heptose and 3-keto-2-deoxyoctonate are absent (Hofstad and 
Kristofferson, 1970). Possibly due to this difference, DIC has not 
~ 
been observed in most clinical ~· fragilis infections (Yoshikawa et 
~~ 
al., 1974). In o animal model of abscess infection, peritonitis 
has been notably absent w as many as 1010 B. fragilis cells were 
placed into the peritoneal cavity of rats. In contrast to this, 108 
cells of E. coli, with its classical endotoxin, resulted in a 50% 
lethality in rats. Various in vivo an~ in vitro assays, such as 
mouse lethality, chick embryo lethality, rabbit biphasicfever respons~ 
Shwartzman reaction and reactivity in the Limulus assay have all been 
used to demonstrate the low toxicity of ~- fragilis endotoxin (Kas-
per, 1976; Sveen and Milner, 1977). No matter how the endotoxin was 
extracted (the phenol-water, trichloroacetic ethylenediamine tetra-
acetic acid, or liquid phenol-chloroform petroleum ether method), 
endotoxic activity as measured by skin inflammation in rabbits, was 
low (Hofstad et al., 1977). This lack of toxicity may explain, in 
part, the inability of ~· fragilis to induce the peritonitis that is 
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so commonly associated with infections caused by other gram negative 
rods. 
Whether or not peritonitis results from spillage, abscess forma-
tion will most likely occur if organisms have been localized by solid 
or semi-solid components of intestinal material. In our animal model, 
the addition of artificial fecal material or blood clots to the bac-
terial inoculum resulted in abscess formation (Table 4, 5, 6, 7, Fig. 
10, 12). It appears that these materials prevent rapid dissemination 
of bacteria through the peritoneal cavity, while allowing inoculated 
bacteria to grow in situ. Other investigators have also demonstrated 
the necessity or potentiating effect of various substances on ability 
of the organisms to cause abscesses. These substances included feces, 
(Deysine et al., 1967) cecal contents and barium sulfate, (Onderdonk 
et al., 1975), mucin (Hill et al., 1974) or semi-solid agar (Walker 
and Wilkins, 1976). 
The body responds to such a localized contamination by surround-
ing and walling off the foreign material with sticky omentum. One 
such factor which might contribute to the walling off process is the 
enzyme heparinase. In a report in 1961, Gesner and Jenkin described 
a heparinase produced'by certain strains of Bacteroides. Many re-
ports (Bodner et al., 197 · Felner and Dowell, 1971; LeFrock et al., 
1976; Nastro and Finegold, 197 have described thrombophlebitis 
associated with human B. fragilis~lnfections. A heparinase has been 
suggested as responsible for this ccurrence. Such an enzyme would 
interfere with normal homeostatic mechanisms i~olved in preventing 
clot formation. It would tend to allow clots to form, resulting in a 
104 
dissemination of disease and possibly phlebitis. However, to this 
point, production of a heparinase by~· fragilis in vivo has never 
been demonstrated. We have found that when~· fragilis was implanted 
into the peritoneal cavity of rats, microthrombi formed by 24 h 
around the area of implantation (data not shown). Control animals 
implanted with E. coli did not form microthrombi. These preliminary 
data suggest that heparinase may indeed be formed. Carrizosa et al. 
(1977) has demonstrated that in a rabbit model of experimental endo-
carditis produced by a nonheparinase producing ~· fragilis subsp. 
vulgatus, phlebitis did not occur. Although vegetations on the heart 
appeared fragile and likely to disseminate, emboli were not found. 
The severity of the abscess, and abscess size, are undoubtedly 
determined by a variety of factors such as inoculum size, inherent 
pathogenic potential of each organism and enhanced pathogenicity due 
to microbial interactions. Surprisingly, size of abscess formed was 
not necessarily due to number of bacteria present in the contaminating 
material. Infection with ~· fragilis alone in our animal model 
uniformly resulted in small absce~s, whether the inoculum size was 
106 organisms or 10,000 time larger able 5). Likewise, the size of 
abscess caused by E. coli remained large whether the inoculum size 
was 105 or 107 cells, at which point animal began to die from peri-
tonitis. A most important observation was that extremely large 
intraperitoneal abscesses were formed even when as low as 10 cells of 
B. fragilis and 10 cells of !· coli were impregnated into artificial 
fecal material and implanted into the peritoneal cavities of rats 
(Table 7). This would, in part, explain the relative ineffectiveness 
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of prophylactic antibiotics in preventing the development of abscess 
infections following colonic surgery. It has been shown (Clark et al., 
1977) that preoperative antibiotics only reduce the level of intes-
tinal bacteria to 103 organisms/g of colonic contents. Undoubtedly, 
reducing the number of bacteria in spillage material will reduce 
chances of infection, especially in terms of peritonitis. However, 
the number of bacteria remaining are more than sufficient to initiate 
abscess formation, especially if bo~h aerobic and anaerobic flora 
are allowed to interact. 
We have described above some of the factors which probably 
determine the outcome of spillage of c~lonic co ents containing 
!· fragilis and E. coli. However, the actual mech nisms of interac-
tion between aerobic and anaerobic bacteria in absce ses and patho-
genic factors elaborated there, are not known. Since I was not 
clear from our data (Table 4, Fig. 10) whether a synergistic inter-
action actually occurred between B. fragilis and !· coli during 
abscess formation, possible mechanisms by which these two organisms 
might interact were investigated in vitro. One such mechanism by 
which B. fragilis and !· coli might interact is the production by 
one or both organisms of substances that are stimulatOfY to the growth 
of the other. To test this possibility, the in vitro growth of these 
organisms in mixed culture was examined. 
The data obtained from in vitro experiments clearly indicates 
that a unilateral stimulation of !· fragilis is occurring. When B. 
fragilis was inoculated alone in certain media, it would not grow 
(Fig. 13, 14, 17). However, when cultured together, E. coli was found 
106 
to stimulate the growth of~· fragilis (Fig. 13, 14, 17). In fact, 
the ~· coli inoculum required for stimulation of ~· fragilis could be 
1 
reduced to as low as 10 cells/ml (Fig. 16). As discussed above, this 
finding is significant in that even low numbers of ~· coli might be 
sufficient to cause mixed anaerobic infection. 
The stimulation of ~· fragilis growth by ~- coli could be demon-
strated in two carefully selected growth media; stored Bacto-peptone 
(Fig. 13, 14, 16) and semi-synthetic (Fig. 17) medium. In both media, 
initial growth of ~- coli appears to be essential for subsequent growth 
of B. fragilis. 
Data obtained from the in vitro study appears to indicate that 
at least three different mechanisms are involved in the stimulation of 
B. fragilis growth by ~- coli. 1. Dissolved oxygen might be removed 
from the media by growth of ~- coli. This reduction in oxygen level 
is necessary before growth of the anaerobe,!· fragilis,can be initi-
ated. 2. Substances that are toxic or inhibitory to B. fragilis 
might be present in the media. If E. coli could metabolize or alter 
---
these substances to a nontoxic form, ~- fragilis might be able to 
grow. 3. !· fragilis might require some unknown factor(s) for its 
growth. It is possible that on growth of ~· ~, these stimulatory 
factors are derived from breakdown products of media components, or 
are formed by E. coli de novo. Each of the above possibilities will 
be discussed below. 
5 When 10 cells of ~· coli were inoculated in Bacto-peptone media 
and incubated aerobically at 37°C, the oxyge level was reduced from 
9.1 to a minimum of 1.03 ~moles/! within a 2 h time period (Fig. 13) • 
• 
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During this time, !· fragilis continually lost viability. We have 
shown that if E. coli was selectively inhibited by an antibiotic 
during the first few hours of growth (Fig. 16), !· fragilis growth was 
not initiated. This indicates that high levels of dissolved oxygen 
might indeed be partially responsible for the inability of B. fragilis 
to grow in such a medium. This view is further supported by the 
facts that stored boiled peptone partially allowed the growth of !· 
fragilis (Table 10) and that the introduction of oxygen to peptone by 
vortexing rendered such a medium unsuitable for B. fragilis growth 
(Table 10). It is quite probable that the rapid scavenging of oxygen 
by E. coli would modify physiologic conditions of infected sites, 
creating an environment more conducive to the growth of B. fragilis. 
However, the elimination of oxygen is not alone sufficient to account 
for the observed stimulation of B. fragilis growth in vitro, since 
(a) reduction in oxygen level in stored peptone by anaerobic incuba-
tion (Table 10) did not allow B. fragilis growth or (b) in spite of 
the relatively high level of dissolved oxygen in other stored pep-
tones (Table 8), B. fragilis was able to grow under certain condi-
tions. In addition, other facultative microorganisms that also 
rapidly reduce oxygen level varied in their ability to enhance !· 
fragilis growth (Table 11). 
Substances toxic to B. fragilis might be present in the stored 
peptone. When the medium was adsorbed with activated charcoal to 
nonspecifically remove certain substances, and then inoculated with 
~· fragilis, slight growth occurred 
(1978) recently demonstrated that a 
(Tabie 13). Carlsson et al. 
va~iety o)f anaerobic broth media, 
~ . . 
~ 
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including Brain Heart infusion (BBL), Trypticase soy broth (BBL), and 
thioglycollate medium (Difco), accumulated hydrogen peroxide and super-
oxide radicals on storage under aerobic condit.ions. Since B. fragilis 
contains little or no catalase (Flen and Rosenblatt, 1976) or super-
oxide dismutase (Tally et al., 1977), the accumulation of such toxic 
substances is certainly detrimental to the survival and growth of B. 
fragilis. However, the data presented in Table 12, which demonstrated 
that superoxide dismutase had little effect. render this possibility 
less likely, although it is still possible that toxic substances 
other than superoxide radicals are metabolized or destroyed by co-
existent E. coli. 
Growth of B. fragilis might be stimulated by substances released 
by !· coli. If the stimulatory substances were cellular components of 
the !· coli, addition of high concentrations of lysed cells should 
enhance growth of !· fragilis. Washed E. coli cells, as concentrated 
8 
as 10 cells/ml, were lysed by various treatments. Addition of these 
lysates, to !· fragilis cultures under anaerobic conditions did not 
stimulate its growth (data not shown). This indicates that enhance-
ment of B. fragilis growth was not due to structural components of 
E. coli. 
Materials, stimulatory to B. fragilis growth, might be actively 
produced and excreted by !· ~into the mediunh We showed (Fig. 15, 
/~/ 
17) that if E. ~ in a mixed culture was selective! inhibited at 
early stages (less than 2 h), growth of !· fragilis wo ld not occur. 
It appears that the accumulation of a threshhold level of stimulatory 
material is necessary to trigger B. fragilis growth, and that this 
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level is achieved before 2 h of growth (Fig. 16). 
It is significant to note that the initial presence of only 
small numbers of E. coli (Fig. 17) is sufficie.nt to produce this 
substance, and that such substances are produced only by certain 
other enterobacteriaceae, but not by Staphylococcus aureus (Table 
11). Vitamins or nutrients produced by one organism have been shown 
to stimulate another microorganism in various mixed culture inter-
actions. In the mutualistic interaction between Proteus vulgaris and 
Bacillus ~. biotin produced by !· vulgaris stimulated B. ~-
myxa and niacin produced by B. polymyxa stimulated !· vulgaris (Yeoh 
et al., 1968). Another study demonstrated~· cerevisiae stimulation 
of a riboflavin requiring Lactobacillus casei (Megee et al., 1972). 
B. melaninogenicus was shown (MacDonald et al., 1963) to be essential 
for the pathogenicity of mixed cultures of organisms isolated from 
periodontal disease. However, another microorganism capable of 
supplying it with required vitamin K was also necessary. The micro-
environment where !· fragilis is normally found (either in the intes-
tine or other infected sites) or the organisms with which they are 
associated, may be capable of providing this organism with essential 
growth stimulatory compounds. Vitamins, such as vitamifi K, breakdown 
products of blood, such as hemin, (Varel and Bryant, 1974; Sperry et 
al., 1971), amino acids (methionine may substitute for the cyanoco-
balamin requirement, Bryant, 1974), ~~des and ammonia (Pitt-
man and Bryant, 1964) are known ~h stimul~~mpounds. If!· 
coli could provide these substances, B. fragilis growth might be 
initiated. However, the data obtained from the present study seem to 
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indicate that stimulatory compounds produced by !· coli are not hemin, 
vitamin K, ammonia, or amino acids, since no stimulation of !· fragilis 
in stored peptone medium has been observed by .the addition of these 
substances (Table 14). 
Iron is known to be a virulence factor for most microorganisms 
(Calver et al., 1976; Wheeler and Hanks, 1965; Weinberg, 1974; Wein-
berg, 1978). Hill demonstrated that iron-containing compounds such as 
blood and hemoglobin enhanced the infection caused by mixed cultures of 
B. fragilis and Peptostreptococcus anaerobius, and that the infection 
enhancing effect could be duplicated by ferric ammonium citrate. Our 
data (Fig. 12) show that a plasma clot impregnated with B. fragilis or 
E. coli and implanted into the peritoneal cavity of rats will not in-
duce abscess formation. However, a blood clot containing the same 
organisms encapsulated and begins to form an abscess by 2 days. In 
contrast to this finding, Bornside and Cohn (1968) cquld find no 
enhancement of virulence when hemoglobin as added to inocula of non-
sporing anaerobic bacteria. 
The human body normally prevents bacterial use of iron by the 
production of iron-binding compounds such as lactoferrin and trans-
ferrin (Bornside and Cohn, 1968; Weinstein, 1978). In spite of this 
host mechanism to deny iron to bacterial invaders, some bacteria, 
such as Salmonella typhimurium (~,,~ty:l97:i) and certain 
strains of !· coli (Payne and Finkelstein, 1977) have the capacity 
to retrieve iron from the iron-lactoferrin complexes by the use of 
siderophores (Wilkins and Lankford, 1970). In fact, the siderophores 
produced by !· coli were able to assist other microorganisms in 
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acquiring needed iron. ~· coli might be performing this function 
when in mixed infections with B. fragilis, although this possibility 
was not investigated. 
Another mechanism by which ~· coli might help prepare the area 
for the growth of ~· fragilis is by its production of SOD. As dis-
cussed earlier, this is one of the means by which facultative organ-
isms protect themselves from byproducts of oxygen metabolism, such 
as superoxide radicals. !· fragilis is normally killed under aerobic 
conditions. If ~· coli destroys these toxic radicals as they are 
formed, !· fragilis might be protected from their lethal effects and 
be allowed to grow. Once initiated, the growth of !· fragilis, as 
well as !· coli growth, would act to keep the area in a reduced state. 
We have demonstrated that the stimulatory substances accumulated 
in spent media are dialyzable (data not shown) and quite stable (Table 
17). By means of an agar diffusion method, it was further demon-
strated that these compounds are able to withstand heat (121°C for 15 
min) and treatment to acid and alkaline conditions {Table 17). The 
stimulatory material produced by !· coli was not ether extractable, 
(Table 17, Fig. 20~, and therefore, probably not lipid in composition. 
It was removed by oth anionic and cationic exchange resins (Table 17, 
Fig. 20), implying that the material contains both positive and nega-
tive charges. Further tudies must be performed before any conclu-
sions concerning the exact nature of this (these) stimulatory 
material(s) can be made. The spent semi-synthetic medium should be 
treated with enzymes that selectively destroy certain bacterial com-
ponents, such as proteins, sugars, or nucleic acids to further identify 
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the general composition of the material. Extraction procedures could 
then be used to concentrate and purify the stimulatory compounds. In 
addition, fractionation procedures would then be used to separate 
actual components participating in the stimulation phenomenon. Various 
electrophoretic and chromatographic techniques would then be employed 
to assist in the identification of these materials. 
From our data (Table 17), it is unlikely that the stimulatory 
compounds are proteinaceous in nature, although certain extracellular 
enzyme proteins such as SOD or iron chelating proteins elaborated by 
one organism may stimulate the growth of bacteria deficient in such 
proteins (Luckey et al., 1972; Payne and Finkelstein, 1978). More 
extensive discussions on these aspects of microbial interactions in 
the pathogenesis of infectious agents are found elsewhere in this 
section. 
The outcome of microbial entry into the peritoneal cavity will 
be determined by type and se of each organism spilled. When the 
number of microorganism is small, they may be rapidly killed by the 
host defense mechanis and no serious infections occur. When a large 
number of bacteria, specially E. coli or other facultative anaerobes 
are introduced, seve peritonitis usually develops. !· fragilis, 
even in high numbers, does not cause severe peritonitis, for still 
undetermined reasons. When, however, !· fragilis and E. coli are 
introduced into the peritoneal cavity together with solid or semi-
solid intestinal contents, the organisms may survive and multiply 
in the localized area which is surrounded by the omentum. It appears 
that the initial growth of E. coli may eventually render the area 
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suitable to the growth of !· fragilis by (a) removing available oxygen, 
thereby lowering the overall oxidation reduction potential, (b) meta-
bolizing oralteringmaterials, such as superoxide radicals, that are 
toxic to the anaerobes, and/or (c) providing !· fragilis with sub-
stances required to, or stimulatory for, the growth of the anaerobe. 
Once B. fragilis begins to grow, it may excrete various extracellular 
enzymes. Heparinase, presumably produced by B. fragilis, could assist 
in this process by causing clot formation and resultant occlusion of 
capillaries. The infection thus becomes a rather closed system, fur-
ther protecting B. fragilis from dissolved oxygen in blood. Enzymes 
produced by !· fragilis, during its growth, such hyaluronidase, 
collagenase, protease, or lipase, could conceivably then destroy host 
tissue and extend the infection. 
I 
components and tissue damage cofld 
attract numerous phagocytic ~ls, 
abdominal abscess formatio~ 
~ 
During this process, bacterial cell 
elicit the inflammatory reaction, 
and eventually result in intra-
SUMMARY 
The interactions between Bpcteroides fragilis and Escherichia 
coli were investigated in~,and in vitro. It was shown that both 
!· fragilis and !· coli /could independently produce intra-abdominal 
abscesses in rats, provided that bacteria were implanted together 
with simulated fecal mat~l. In this study, no strong evidence was 
obtained which indicates that a synergistic interaction between 
obligate and facultative anaerobes plays an important role in intra-
abdominal abscess formation. The formation of intraperitoneal 
abscesses was found to be influenced by several factors, such as the 
nature of materials in which organisms were impregnated, type of 
bacteria used, and the inherent pathogenicity of each organism. The 
presence of solid or semi-solid material was found to be necessary for 
the induction of intra-abdominal abscesses. If properly inoculated, 
even low numbers of bacteria were able to produce abscesses. The 
number of bacteria inoculated did not affect the ultimate weight of 
the abscess. However, if too high a number of !· coli was inoculated 
(> 108 microorganisms) death from peritonitis invariably resulted. In 
contrast to this, no animals died from peritonitis even when very 
large doses of B. fragilis were used (1010 microorganisms). 
When !· fragilis and !· coli were incubated together in media 
that would not allow the growth of B. fragilis, growth of the anaerobe 
was stimulated. Under our experimental conditions, approximately 2 h 
of !· coli growth was required before an increase in viable number of 
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~· fragilis was observed. Other {nteric 
vulgaris and Klebsiella pneumoniae~ 
organisms, such as Proteus 
also found to enhance the 
growth of!· fragilis, although Staphylococcus aureus would not. At 
least three mechanisms appear to be responsible for the stimulation 
of B. fragilis growth by!· coli: 1. Dissolved oxygen is removed 
from the media by E. coli, lowering the overall oxidation-reduction 
potential. 2. Substances that are toxic to B. fragilis are detoxi-
fied by E. coli. 3. !· coli provides some as yet unidentified com-
pound(s) required for, or stimulatory to, the growth of!· fragilis. 
The stimulatory compound(s) accumulated in media by the growth of 
!· coli was dialyzable and quite stable to heat (121°C for 15 min) 
or mild acid and alkali treatments. It was not extractable by ether, 
but was removed by both anionic and cationic resins. Based on the 
data obtained in this investigation and those reported in the litera-
ture, a possible mechanism of anaerobic intra-abdominal abscess 
formation was proposed. 
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